20140102 8:30AM UTC,Johnson & Johnson Announces Quarterly Dividend for First Quarter 2014,http://www.reuters.com/article/2014/01/02/johnsonjohnson-div-idUSnPnNYgzqhY+161+PRN20140102,
20140103 9:30AM UTC,"Broadridge Financial Solutions, VeriFone Systems, Gilead Sciences, Johnson & Johnson and Forest Laboratories highlighted as Zacks Bull and Bear of the Day",http://www.reuters.com/article/2014/01/03/il-zacks-investments-idUSnPnCGgLwkT+169+PRN20140103,
20140107 8:00AM UTC,"Upcoming Conference Participations, Cash Dividends, and Share Price Movements - Research Report on Johnson & Johnson, Boston Scientific, NuVasive, Exelixis, and Healthways",http://www.reuters.com/article/2014/01/07/bc-analysts-corner-idUSnPn7zpghn+80+PRN20140107,
20140108 6:17PM UTC,Janssen Pharmaceutical Companies of Johnson & Johnson Submit Citizen Petition to the U.S. FDA Regarding Naming of Biosimilars,http://www.reuters.com/article/2014/01/08/janssen-petition-fda-idUSnPnDCj0nFC+163+PRN20140108,
20140108 8:00AM UTC,"Johnson & Johnson Innovation Expands Global Incubator Presence to Israel and Announces Multiple, Diverse, Early-Stage Collaborations with Academia and Biotech",http://www.reuters.com/article/2014/01/08/nj-johnson-johnson-idUSnBw085519a+100+BSW20140108,
20140108 8:00AM UTC,Scholar Rock Announces Collaboration with Johnson & Johnson Innovation to Discover and Develop Novel Biologics for the Treatment of Autoimmune Diseases and Cancer,http://www.reuters.com/article/2014/01/08/ma-scholar-rock-idUSnBw085574a+100+BSW20140108,
20140108 8:00AM UTC,Nodality Enters into a Strategic Collaboration with Johnson & Johnson Innovation in Autoimmune Diseases,http://www.reuters.com/article/2014/01/08/ca-nodality-idUSnBw085105a+100+BSW20140108,
20140109 9:52AM UTC,"Research and Markets: Urinary Incontinence Global Clinical Trials Review, H2 2013 Report Features Players such as Allergan, Inc., Johnson & Johnson and Boehringer Ingelheim GmbH",http://www.reuters.com/article/2014/01/09/research-and-markets-idUSnBw095743a+100+BSW20140109,
20140109 9:00AM UTC,"Johnson & Johnson Official 7 Minute Workout App Now Available For iPhone, iPad, iPod touch and Android Smartphones and Tablets",http://www.reuters.com/article/2014/01/09/mi-wellnesspreventio-idUSnPnCGhQlkj+168+PRN20140109,
20140109 5:06AM UTC,Johnson & Johnson to appeal China revoking diabetes trademark,http://www.reuters.com/article/2014/01/09/us-johnsonjohnson-china-idUSBREA080D720140109,
20140109 5:02AM UTC,Johnson & Johnson to appeal China revoking diabetes trademark,http://www.reuters.com/article/2014/01/09/johnsonjohnson-china-idUSL3N0KJ2R020140109,
20140110 8:00AM UTC,"Clinical Study Updates, Milestones Achievements, and Stock Price Movements - Research Report on Johnson & Johnson, Epizyme, Health Management, DENTSPLY, and Charles River",http://www.reuters.com/article/2014/01/10/bc-analysts-corner-idUSnPn7ND5hn+98+PRN20140110,
20140113 11:08AM UTC,Adaptive Announces a Biomarker Discovery Agreement with Johnson & Johnson Innovation,http://www.reuters.com/article/2014/01/13/adaptive-newagreement-idUSnPnSFjBspj+168+PRN20140113,
20140114 9:49AM UTC,Leading Life Sciences CEOs Honor Johnson & Johnson Chief Scientific Officer Paul Stoffels with Lifetime Achievement Award at Annual East/West CEO Conference,http://www.reuters.com/article/2014/01/14/ca-east-west-ceo-conf-idUSnBw146056a+100+BSW20140114,
20140114 8:00AM UTC,"Healthcare Companies Report Petition Submission, Pricing of Follow-On Offerings and Stock Price Movements - Research Report on Johnson & Johnson, GW Pharma, Conatus Pharma, Chelsea, and Insmed",http://www.reuters.com/article/2014/01/14/bc-ac-idUSnPn84wvhn+80+PRN20140114,
20140116 7:45AM UTC,Johnson & Johnson Announces Binding Offer From The Carlyle Group To Acquire Ortho-Clinical Diagnostics,http://www.reuters.com/article/2014/01/16/johnsonjohnson-merge-idUSnPnNYkClgk+168+PRN20140116,
20140116 7:45AM UTC,The Carlyle Group Agrees to Acquire Johnson & Johnsonâ€™s Ortho-Clinical Diagnostics for $4.15 Billion,http://www.reuters.com/article/2014/01/16/ny-the-carlyle-group-idUSnBw165686a+100+BSW20140116,
20140121 12:38PM UTC,MD Anderson Announces Collaboration With Johnson & Johnson Innovation On Cancer Immunotherapy,http://www.reuters.com/article/2014/01/21/mdandersonimmunothrpy-idUSnPnDClfbpc+160+PRN20140121,
20140121 7:57AM UTC,Johnson & Johnson beats Q4 forecasts as drug sales shine,http://www.reuters.com/article/2014/01/21/johnsonandjohnson-results-idUSL2N0KV01Q20140121,
20140121 7:45AM UTC,Johnson & Johnson Reports 2013 Fourth-Quarter and Full-Year Results:,http://www.reuters.com/article/2014/01/21/johnsonjohnson-earns-idUSnPnNYlk4gk+160+PRN20140121,
20140122 11:28AM UTC,"DePuy ASR Lawsuit News: DePuy ASR Hip Recall Continues to Impact Johnson & Johnson Earnings, Bernstein Liebhard LLP Reports",http://www.reuters.com/article/2014/01/22/ny-bernstein-liebhard-idUSnPnNYlMvpH+169+PRN20140122,
20140129 11:21AM UTC,"Risperdal Lawsuit News: Johnson & Johnson Wins Appeal of $257 Million Louisiana Risperdal Verdict, Bernstein Liebhard LLP Reports",http://www.reuters.com/article/2014/01/29/ny-bernstein-suitnews-idUSnPnNYnnzpy+160+PRN20140129,
20140130 8:00AM UTC,Johnson & Johnson Announces Clinical Trial Data Sharing Agreement With Yale School of Medicine,http://www.reuters.com/article/2014/01/30/johnsonjohnson-yoda-idUSnPnNYnCWhn+16c+PRN20140130,
20140130 12:01AM UTC,Johnson & Johnson Announces Clinical Trial Data Sharing Agreement With Yale School of Medicine,http://www.reuters.com/article/2014/01/30/johnsonjohnson-yoda-idUSnPnNYnbf1+b0+PRN20140130,
20140203 9:00AM UTC,Johnson & Johnson Issues Dr. Paul Janssen Award for Biomedical Research Call for Nominations,http://www.reuters.com/article/2014/02/03/johnsonjohnson-award-idUSnPnNYp74kj+160+PRN20140203,
20140211 9:00AM UTC,Johnson & Johnson and Scientists Without Borders Announce Winners of Mental Health Awareness Challenge,http://www.reuters.com/article/2014/02/11/ny-johnsonjohnson-idUSnPnNYr4Nkj+164+PRN20140211,
20140214 3:30PM UTC,Decision Diagnostics Announces Agreement for the Funding of Its Prosecution of Anti-Trust and False Advertising Suits Against Division of Johnson & Johnson,http://www.reuters.com/article/2014/02/14/idUSnMKW38LP9a+1cc+MKW20140214,
20140214 7:45AM UTC,Johnson & Johnson to Participate in 2014 Citi Global Health Care Conference,http://www.reuters.com/article/2014/02/14/johnsonjohnsonconf-idUSnPnNYs80gk+160+PRN20140214,
20140218 11:25AM UTC,Decision Diagnostics Announces Agreement for Funding of Its Prosecution of Anti-Trust and False Advertising Suits Against Division of Johnson & Johnson,http://www.reuters.com/article/2014/02/18/idUSnMKW4TB5Qa+1da+MKW20140218,
20140221 9:30AM UTC,"The Zacks Analyst Blog Highlights: Priceline, Groupon, Bayer, Johnson & Johnson and Alexion Pharmaceuticals",http://www.reuters.com/article/2014/02/21/il-zacks-investment-idUSnPnCGtFYkT+16d+PRN20140221,
20140225 7:45AM UTC,Johnson & Johnson to Participate in 2014 Cowen 34th Annual Health Care Conference,http://www.reuters.com/article/2014/02/25/johnsonjohnsoncowen-idUSnPnNYvgngk+160+PRN20140225,
20140226 4:46PM UTC,"Research and Markets: North America Weight Loss/Obesity Management Market - Forecasts to 2017: Featuring Players such as Atkins Nutritionals, Inc and Johnson & Johnson",http://www.reuters.com/article/2014/02/26/research-and-markets-idUSnBw266685a+100+BSW20140226,
20140228 11:31AM UTC,"Risperdal Lawsuit News: Arkansas Supreme Court Hears Johnson & Johnson Appeal of $1.2 Billion Risperdal Verdict, Bernstein Liebhard LLP Reports.",http://www.reuters.com/article/2014/02/28/ny-bernstein-liebhard-idUSnPnNYwwMpL+165+PRN20140228,
20140306 1:52PM UTC,"Johnson & Johnson Launches Champions of Care"" Program in the U.S as Part of 2014 FIFA World Cupâ„¢ Sponsorship""",http://www.reuters.com/article/2014/03/06/nj-johnsonjohnson-idUSnPnCGy0Jv0+164+PRN20140306,
20140310 8:00AM UTC,Alector Teams Up with Johnson & Johnson Innovation to Explore Novel Alzheimer's Target,http://www.reuters.com/article/2014/03/10/alector-alzheimers-idUSnPnLAynPhn+164+PRN20140310,
20140310 4:52AM UTC,BRIEF-Reckitt Benckiser to buy K-Y brand from Johnson & Johnson's unit,http://www.reuters.com/article/2014/03/10/reckittbenckiser-brief-idUSWLB007KH20140310,
20140310 4:43AM UTC,Reckitt Benckiser to buy K-Y from Johnson & Johnson,http://www.reuters.com/article/2014/03/10/us-reckittbenckiser-ky-idUSBREA290BZ20140310,
20140310 4:41AM UTC,Reckitt Benckiser to buy K-Y from Johnson & Johnson,http://www.reuters.com/article/2014/03/10/reckittbenckiser-ky-idUSL6N0M70WN20140310,
20140311 4:15PM UTC,Johnson & Johnson to Host Analyst Conference Call on First-Quarter Results,http://www.reuters.com/article/2014/03/11/nj-jj-q1-conf-call-idUSnPnNYz4hB3+162+PRN20140311,
20140312 8:00AM UTC,"Collaborations, Treatment Approvals, New Solutions, Clinical Trial Results, and New Drug Applications - Analyst Notes on Biogen Idec, Johnson & Johnson, Express Scripts, Merck, and Forest Laboratories",http://www.reuters.com/article/2014/03/12/bc-analysts-review-idUSnPnqbXthn+88+PRN20140312,
20140331 7:45AM UTC,Johnson & Johnson Announces Acceptance Of Binding Offer From The Carlyle Group To Acquire Ortho-Clinical Diagnostics,http://www.reuters.com/article/2014/03/31/jj-orthoclin-acquire-idUSnPn9pQ9V6+8a+PRN20140331,
20140804 8:50AM UTC,"Drug Approvals and Earnings Releases - Research Reports on Bristol-Myers, Johnson & Johnson, Merck, Pharmacyclics and Amgen",http://www.reuters.com/article/2014/08/04/bc-ar-idUSnPnbhrQ3h+84+PRN20140804,
20140822 9:30AM UTC,"The Zacks Analyst Blog Highlights: Johnson & Johnson, Tekmira Pharmaceuticals, GileadSciences, Allergan and Supernus Pharmaceuticals",http://www.reuters.com/article/2014/08/21/il-zacks-investment-idUSnPn78qKWr+86+PRN20140821,
20140822 9:20AM UTC,"Research and Markets: Global Medical Devices Market Report 2014-2018: Covidien, F. Hoffmann-La Roche, GE Healthcare, Johnson & Johnson & Medtronic Dominate the Industry",http://www.reuters.com/article/2014/08/21/research-and-markets-idUSnBw215601a+100+BSW20140821,
20140909 9:30AM UTC,"The Zacks Analyst Blog Highlights: Intel, Advanced Micro Devices, Johnson & Johnson, Bayer and McDonald's",http://www.reuters.com/article/2014/09/08/ilzacksinvestmentblog-idUSnPng7Kml+44+PRN20140908,
20141015 7:45AM UTC,Johnson & Johnson Reports 2014 Third-Quarter Results:,http://www.reuters.com/article/2014/10/14/ny-johnsonjohnson-idUSnPn5GvRN5+96+PRN20141014,
20141120 8:20PM UTC,Johnson & Johnson Partners with Save the Children to Help Millions of Children over the Next Three Years,http://www.reuters.com/article/2014/11/20/jj-save-the-children-idUSnPn7TrLPF+97+PRN20141120,
20141120 1:37AM UTC,BRIEF-Raisio acquired Benecol business from affiliates of Johnson & Johnson,http://www.reuters.com/article/2014/11/19/raisio-brief-idUSFWN0T803520141119,
20140319 8:00AM UTC,"Health Care Stocks Review -- Research on Bristol-Myers Squibb, Johnson & Johnson, Merck & Co. and Eli Lilly",http://www.reuters.com/article/2014/03/19/bc-ie-idUSnPn84H60N+89+PRN20140319,
20140320 11:46AM UTC,BRIEF-Johnson & Johnson wins reversal of $1.2 bln Risperdal judgment,http://www.reuters.com/article/2014/03/20/johnsonandjohnson-brief-idUSWEN00CQV20140320,
20140320 8:00AM UTC,"Healthcare Companies Report FDA Approvals, Comprehensive Analysis, Schedules, and Stock Movements - Analyst Notes on Pfizer, Johnson & Johnson, Biogen, Express Scripts, and Forest Laboratories",http://www.reuters.com/article/2014/03/20/bc-ar-idUSnPn21yXBx+86+PRN20140320,
20140321 7:45AM UTC,Johnson & Johnson to Webcast Annual Meeting of Shareholders,http://www.reuters.com/article/2014/03/21/johnsonjohnson-cast-idUSnPnbQ35H5+92+PRN20140321,
20140324 9:30AM UTC,"Gain Capital Holdings, Vail Resorts, Johnson & Johnson, Alkermes and Alexion Pharmaceuticals highlighted as Zacks Bull and Bear of the Day",http://www.reuters.com/article/2014/03/24/zacks-investment-idUSnPnb9vKZc+86+PRN20140324,
20140327 3:08PM UTC,Fitch Affirms Johnson & Johnson at 'AAA'; Outlook Stable,http://www.reuters.com/article/2014/03/27/ny-fitch-ratings-jnj-idUSnBw276287a+100+BSW20140327,
20140327 2:58PM UTC,Fitch Affirms Johnson & Johnson at 'AAA'; Outlook Stable,http://www.reuters.com/article/2014/03/27/fitch-affirms-johnson-johnson-at-aaa-out-idUSFit69465220140327,
20140328 8:00AM UTC,"Positive Opinions, Presentation Schedules of Investigational Data, Clinical Study Results, and Stock Price Movements - Analyst Notes on Johnson & Johnson, Merck, Pfizer, Amgen, and Allergan",http://www.reuters.com/article/2014/03/28/bc-analysts-review-idUSnPnbFJ7c4+98+PRN20140328,
20140401 12:09PM UTC,Johnson & Johnson Enters Agreement to be Official Healthcare Partner of the USO,http://www.reuters.com/article/2014/04/01/johnsonjohnson-uso-idUSnPn2yzgvR+81+PRN20140401,
20140402 9:30AM UTC,"The Zacks Analyst Blog Highlights: Microsoft, Hewlett-Packard, Google, Apple and Johnson & Johnson",http://www.reuters.com/article/2014/04/02/zacks-equity-research-idUSnPnqn2St+42+PRN20140402,
20140403 8:02AM UTC,"Healthcare Companies Report Transactions, Appeals, New Research Findings and Stock Movements - Analyst Notes on Johnson & Johnson, Teva, Celgene, Cara Therapeutics, and OncoMed Pharmaceuticals",http://www.reuters.com/article/2014/04/03/bc-analystsreviewcom-idUSnPnbKHvpc+98+PRN20140403,
20140407 12:35PM UTC,"Technical Pointers on Pharmaceuticals Equities -- Research on Merck, Bristol-Myers Squibb, Johnson & Johnson, and Eli Lilly",http://www.reuters.com/article/2014/04/07/bc-ie-idUSnPn7mLfmt+88+PRN20140407,
20140407 8:01AM UTC,"NDA Filings, FDA Approvals, Executive Appointments, Ceased Clinical Trials, and Public Offerings - Analyst Notes on Johnson & Johnson, Pfizer, Merck, GSK, and Intercept",http://www.reuters.com/article/2014/04/07/bc-analysts-review-idUSnPn7vZLT5+8e+PRN20140407,
20140408 8:01AM UTC,"Conference Call Schedules, Clinical Trial Studies, Awards and Accolades, Appointments, and Welfare Initiatives - Analyst Notes on Celgene, Johnson & Johnson, Merck, Sanofi, and UnitedHealth",http://www.reuters.com/article/2014/04/08/bc-analysts-review-idUSnPn2NrqJj+92+PRN20140408,
20140409 2:21PM UTC,UniStrip Technologies Introduces Generic Blood Glucose Test Strips For Use With Johnson & Johnson's OneTouchÂ® UltraÂ® Meters.,http://www.reuters.com/article/2014/04/09/nc-unistrip-generic-idUSnPn7rtXwQ+85+PRN20140409,
20140415 7:45AM UTC,Johnson & Johnson Reports 2014 First-Quarter Results:,http://www.reuters.com/article/2014/04/15/nj-jj-q1-earnings-idUSnPnFhCWK+57+PRN20140415,
20140421 9:30AM UTC,"The Zacks Analyst Blog Highlights:JPMorgan, Pfizer, Coca-Cola, Johnson & Johnson and IBM",http://www.reuters.com/article/2014/04/21/zacks-equity-research-idUSnPn4db1FB+83+PRN20140421,
20140422 6:23AM UTC,"Research and Markets: Global Arthroscopy Devices Market 2014-2018 with Arthrex Inc., CONMED Corp., Johnson & Johnson and Smith & Nephew Dominating",http://www.reuters.com/article/2014/04/22/research-and-markets-idUSnBw225737a+100+BSW20140422,
20140423 2:00PM UTC,"Compliance and ethics case studies offered by Dell, Aetna, Bain Capital, Mercer, The Nature Conservancy, Johnson & Johnson, Gallup and others to be featured at SCCE's 13th Annual Compliance & Ethics Institute",http://www.reuters.com/article/2014/04/23/scce-ethics-institute-idUSnPncgJpWB+8b+PRN20140423,
20140423 2:00PM UTC,Johnson & Johnson to Host Medical Devices & Diagnostics Business Review,http://www.reuters.com/article/2014/04/23/nj-jnj-hosts-review-idUSnPnb5XBQB+8f+PRN20140423,
20140424 2:11PM UTC,"Research and Markets: United States Facial Care Market 2014-2018 with Johnson & Johnson, L'OrÃ©al, Procter & Gamble & Unilever Group Dominating the $13 Billion Industry",http://www.reuters.com/article/2014/04/24/research-and-markets-idUSnBw246423a+100+BSW20140424,
20140424 10:22AM UTC,Johnson & Johnson Announces Dividend Increase of 6.1%,http://www.reuters.com/article/2014/04/24/johnsonjohnson-div-idUSnPn5VP80l+98+PRN20140424,
20140424 8:00AM UTC,"Quarterly Results, FDA Approvals, Intellectual Property Appeals, New Drug Applications, and Initiated Clinical Trials - Analyst Notes on Johnson & Johnson, Merck, Teva, Bristol-Myers Squibb and AbbVie",http://www.reuters.com/article/2014/04/24/bc-a-idUSnPn8Z5y4M+91+PRN20140424,
20140425 8:00AM UTC,"Drug Approvals, Quarterly Earnings Releases, and Stock Price Updates - Analyst Notes on Merck, Johnson & Johnson, UnitedHealth, Celgene and GW",http://www.reuters.com/article/2014/04/25/bc-analysts-review-idUSnPn6xMcht+88+PRN20140425,
20140429 12:04PM UTC,"Technical Briefing on Equities Reaching New high -- Research on Johnson & Johnson, Berkshire Hathaway, HollyFrontier, and Crown Holdings",http://www.reuters.com/article/2014/04/29/bc-i-idUSnPnbT5jrb+90+PRN20140429,
20140429 8:30AM UTC,Johnson & Johnson Announces New Collaboration with Stop TB Partnership's Global Drug Facility to Enhance Access to Anti-TB Compound,http://www.reuters.com/article/2014/04/29/nj-johnsonjohnson-idUSnPn2Jn4Yt+92+PRN20140429,
20140430 8:00AM UTC,Johnson & Johnson and American College of Sports Medicine Form Global Alliance to Advance Human Health and Performance,http://www.reuters.com/article/2014/04/30/ny-jjallhumhealperf-idUSnPn6ZbbK8+92+PRN20140430,
20140502 8:01AM UTC,"Approvals from the European Commission and Release of Quarterly Financial Results - Analyst Notes on Merck, Johnson & Johnson, Bristol-Myers Squibb, Teva and AbbVie",http://www.reuters.com/article/2014/05/02/bc-analysts-review-idUSnPn6TV8kV+99+PRN20140502,
20140505 3:54PM UTC,"Johnson & Johnson Announces U.S. Champions of Care"" Program Finalists as Part of 2014 FIFA World Cup Brazilâ„¢ Sponsorship""",http://www.reuters.com/article/2014/05/05/johnson-johnson-idUSnPn5cbwD8+82+PRN20140505,
20140505 8:00AM UTC,"Stock Movements, Senior Level Appointments, Quarterly Earnings Release, New Agreement, and Drug Approvals - Analyst Notes on Sallie Mae, Visa, MasterCard, Willis and Johnson & Johnson",http://www.reuters.com/article/2014/05/05/bc-analystsreviewcom-idUSnPn9Jnkbz+90+PRN20140505,
20140507 10:00AM UTC,Corporate Action Network: Injured Women Call on Johnson & Johnson to Immediately Stop Producing Dangerous Pelvic Mesh Implants,http://www.reuters.com/article/2014/05/07/nj-corp-action-network-idUSnBw075446a+100+BSW20140507,
20140508 9:30AM UTC,"The Zacks Analyst Blog Highlights:Ruth's Hospitality Group, Denny's, Bayer, Merck and Johnson & Johnson",http://www.reuters.com/article/2014/05/08/zacks-analyst-blog-idUSnPn45gPq8+84+PRN20140508,
20140512 3:37PM UTC,"Research and Markets: Global Wipes Market 2014-2018: Johnson & Johnson Inc., Kao Corp., Kimberly-Clark Corp., and Procter & Gamble Co. Dominate the Market",http://www.reuters.com/article/2014/05/12/research-and-markets-idUSnBw126556a+100+BSW20140512,
20140512 8:00AM UTC,"Earnings Results, Agreements, Study Results, FDA Approvals, and Drug Trial Results - Analyst Notes on Merck, Johnson & Johnson, GlaxoSmithKline, Novartis and Intercept",http://www.reuters.com/article/2014/05/12/bc-ar-idUSnPn5YYpMv+9a+PRN20140512,
20140513 7:29AM UTC,"Research and Markets: Global Tampons Market 2014-2018: Energizer Holdings Inc, Johnson & Johnson Inc, Kimberly-Clark Corp & Procter & Gamble Co. Dominates",http://www.reuters.com/article/2014/05/13/research-and-markets-idUSnBw135896a+100+BSW20140513,
20140521 11:27AM UTC,"Market Movers - Health Care Sector Stocks -- Research on VCA Antech, MEDNAX, Lannett, and Johnson & Johnson",http://www.reuters.com/article/2014/05/21/bc-investor-edge-idUSnPn5WTdlP+99+PRN20140521,
20140521 8:42AM UTC,"Marketing Authorizations, Study Results Presentations, FDA Response to Drug Application, and New Messaging Services - Analyst Notes on Johnson & Johnson, Merck, Celgene, Novartis and UnitedHealth",http://www.reuters.com/article/2014/05/21/bc-analysts-review-idUSnPn11QdLs+8a+PRN20140521,
20140522 8:45AM UTC,Johnson & Johnson Medical Devices & Diagnostics Businesses Expanding Market Leadership with Innovative Products and Customer-Focused Solutions,http://www.reuters.com/article/2014/05/22/nj-johnson-johnson-idUSnPn1lZV9j+8c+PRN20140522,
20140529 8:00AM UTC,Aduro Announces License Agreement with Johnson & Johnson Innovation for Novel Immunotherapies for Prostate Cancer,http://www.reuters.com/article/2014/05/29/ca-aduro-biotech-idUSnBw295343a+100+BSW20140529,
20140529 7:57AM UTC,China fines Johnson & Johnson and others for price fixing,http://www.reuters.com/article/2014/05/29/us-china-penalty-idUSKBN0E915920140529,
20140529 7:53AM UTC,China fines Johnson & Johnson and others for price fixing,http://www.reuters.com/article/2014/05/29/china-penalty-idUSL3N0OF2U520140529,
20140529 6:50AM UTC,"Launch of Ultrasonic Device, Conference Participation, Public Offering, and Employee Stock Options - Analyst Notes on Johnson & Johnson, McKesson, AmerisourceBergen, Horizon Pharma and Sanofi",http://www.reuters.com/article/2014/05/29/bc-ar-idUSnPnbS1K0x+94+PRN20140529,
20140530 5:33PM UTC,Hysterectomy Cancer Lawsuit: Bernstein Liebhard Notes Report Indicating Johnson & Johnson Was Warned About Morcellator Cancer Risks in 2006,http://www.reuters.com/article/2014/05/30/ny-bernsteinlawreport-idUSnPnb39jLX+83+PRN20140530,
20140530 1:21PM UTC,"Research and Markets: Endothelial Dysfunction - Pipeline Review, H1 2014: Johnson & Johnson, Chugai Pharmaceutical Co., Ltd., Glucox Biotech AB & Stealth Pep",http://www.reuters.com/article/2014/05/30/research-and-markets-idUSnBw305740a+100+BSW20140530,
20140603 9:30AM UTC,"Gorman Rupp, American Vanguard, Pharmacyclics, GlaxoSmithKline andJohnson & Johnson highlighted as Zacks Bull and Bear of the Day",http://www.reuters.com/article/2014/06/03/il-zacks-investment-idUSnPn1xQjDh+8a+PRN20140603,
20140604 3:01PM UTC,Johnson & Johnson Reinforces Importance of Children Learning the Value of Care from their Parents as Part of CARE INSPIRES CAREâ„¢ Program,http://www.reuters.com/article/2014/06/04/johnsonjohnson-care-idUSnPn9TmsFz+92+PRN20140604,
20140605 12:30PM UTC,"Johnson & Johnson Announces U.S. Champions of Care"" as Part of 2014 FIFA World Cup Brazilâ„¢ Sponsorship""",http://www.reuters.com/article/2014/06/05/nj-johnsonjohnson-idUSnPn1TXxqV+99+PRN20140605,
20140605 6:10AM UTC,"Study Results, Updated Organization Structures, Appointments, and Technical Updates - Analyst Notes on Johnson & Johnson, Pfizer, Teva, Express Scripts and Idenix Pharmaceuticals",http://www.reuters.com/article/2014/06/05/bc-ar-idUSnPn7gWV5M+8d+PRN20140605,
20140612 6:25PM UTC,Corporate Action Network and Injured Women Call on Illinois Attorney General to Investigate Johnson & Johnson,http://www.reuters.com/article/2014/06/12/il-corp-action-network-idUSnBw126467a+100+BSW20140612,
20140612 6:21PM UTC,Corporate Action Network and Injured Women Call on Mississippi Attorney General to Investigate Johnson & Johnson,http://www.reuters.com/article/2014/06/12/ms-corp-action-network-idUSnBw126465a+100+BSW20140612,
20140612 9:30AM UTC,"The Zacks Analyst Blog Highlights: Pepsico, Nike, Yingli Green Energy Holding and Johnson & Johnson",http://www.reuters.com/article/2014/06/12/il-zacks-investment-idUSnPn2SDBzt+9c+PRN20140612,
20140613 6:00AM UTC,"Approvals, Agreements, Name Change, and Partnerships - Analyst Notes on Johnson & Johnson, Furiex Pharmaceuticals, Select Medical, CTI and Hill-Rom",http://www.reuters.com/article/2014/06/13/bc-analysts-review-idUSnPn8hZsWH+8b+PRN20140613,
20140616 9:30AM UTC,"The Zacks Analyst Blog Highlights: Johnson & Johnson, GlaxoSmithKline, Pfizer  and Gilead Sciences",http://www.reuters.com/article/2014/06/16/il-zacks-analyst-blog-idUSnPn4G8CBR+97+PRN20140616,
20140617 5:00PM UTC,Johnson & Johnson to Host Investor Conference Call on Second-Quarter Results,http://www.reuters.com/article/2014/06/17/johnsonjohnson-conf-idUSnPn8H6Hcx+94+PRN20140617,
20140617 9:30AM UTC,"RF Micro Devices, Select Income Reality, TriQuint Semi, Medtronic,Covidien, Johnson & Johnson, iShares U.S. Medical Devices ETF, Pfizer and AstraZeneca highlighted as Zacks Bull and Bear of the Day",http://www.reuters.com/article/2014/06/17/il-zacksinvestment-idUSnPn8HB3Xt+9a+PRN20140617,
20140619 3:45PM UTC,Corporate Action Network and Florida Women Demand State Investigation of Johnson & Johnson for Dangerous Mesh Implants,http://www.reuters.com/article/2014/06/19/fl-can-call-for-action-idUSnBw196500a+100+BSW20140619,
20140619 8:00AM UTC,"Johnson & Johnson Innovation Catalyzes New and Exciting Science and Technology in Pharmaceutical, Medical Device, Diagnostic and Consumer Healthcare Spaces",http://www.reuters.com/article/2014/06/19/nj-johnson-johnson-idUSnPn6pQXFB+8f+PRN20140619,
20140619 8:00AM UTC,"CEO and Chairman of UPS, D. Scott Davis, Joins Johnson & Johnson Board of Directors",http://www.reuters.com/article/2014/06/19/johnsonjohnson-elect-idUSnPn5Tjntp+90+PRN20140619,
20140620 2:00PM UTC,Corporate Action Network and South Carolina Women Call For State Investigation Into Johnson & Johnson for Dangerous Mesh Implants,http://www.reuters.com/article/2014/06/20/sc-can-call-for-action-idUSnBw205725a+100+BSW20140620,
20140620 6:10AM UTC,"Conference Call Schedules, Acquisitions, and Public Offerings - Analyst Notes on Johnson & Johnson, Merck, GW, Endocyte and AVEO",http://www.reuters.com/article/2014/06/20/bc-analysts-review-idUSnPn6bwD7D+85+PRN20140620,
20140623 9:30AM UTC,"The Zacks Analyst Blog Highlights: Intel, Boeing, Chevron, Johnson & Johnson and Vertex Pharmaceuticals",http://www.reuters.com/article/2014/06/23/il-zacksinvestment-idUSnPn4bLpDV+8b+PRN20140623,
20140624 9:30AM UTC,"The Zacks Analyst Blog Highlights: Moody's, Anheuser-Busch InBev, Coca-Cola, Yahoo!, SINA, Sony, Yingli Green Energy Holding, McDonald's, Visa and Johnson & Johnson",http://www.reuters.com/article/2014/06/24/il-zacks-investment-idUSnPnc97dQb+82+PRN20140624,
20140624 8:00AM UTC,Johnson & Johnson Innovation Announces Immuno-Oncology Lung Cancer Collaboration with the Dana-Farber Cancer Institute's Belfer Institute for Applied Cancer Science,http://www.reuters.com/article/2014/06/24/ma-johnsonjohnson-idUSnPn9s1wS7+82+PRN20140624,
20140626 8:04AM UTC,One Mind Institute (IMHRO) Announces 2014 IMHRO/Johnson & Johnson Rising Star Research Awards,http://www.reuters.com/article/2014/06/26/ca-imhro-idUSnBw265386a+100+BSW20140626,
20140630 4:30PM UTC,Johnson & Johnson Completes Divestiture Of Ortho-Clinical Diagnostics To The Carlyle Group,http://www.reuters.com/article/2014/06/30/nj-jj-divestiture-idUSnPnlM9HD+4b+PRN20140630,
20140630 5:20AM UTC,"Scheduled Conference Calls, License Agreements, Dividends, Preliminary Proxy statements and Initiation of Clinical Studies - Analyst Notes on Merck, Johnson & Johnson, AbbVie, Valeant and GSK",http://www.reuters.com/article/2014/06/30/bc-analystsreviewcom-idUSnPn7L5T2V+95+PRN20140630,
20140710 5:00AM UTC,"New Board Director, Clinical Trial Results, New Drug Designations and Marketing Authorizations - Analyst Notes on Johnson & Johnson, Merck, Novartis, GSK and Endo",http://www.reuters.com/article/2014/07/10/bc-analystsreviewcom-idUSnPn5dmp2C+81+PRN20140710,
20140711 8:55PM UTC,USHCC Applauds Johnson & Johnson for Joining President Obama's Supply Chain Initiative,http://www.reuters.com/article/2014/07/12/idUSnGNX8n6XrC+1c5+GNW20140712,
20140715 7:45AM UTC,Johnson & Johnson Reports 2014 Second-Quarter Results:,http://www.reuters.com/article/2014/07/15/johnsonjohnson-earns-idUSnPn786QzQ+85+PRN20140715,
20140721 5:00PM UTC,Johnson & Johnson Announces $5 Billion Share Repurchase Program,http://www.reuters.com/article/2014/07/21/jj-share-repurchase-idUSnPn30wKq9+84+PRN20140721,
20140721 11:10AM UTC,Johnson & Johnson Announces Quarterly Dividend for Third Quarter 2014,http://www.reuters.com/article/2014/07/21/nj-johnsonjohnsondiv-idUSnPnkNSc4+4c+PRN20140721,
20140722 6:50AM UTC,"Research and Markets: Global IVD Market 2014-2018 with Abbott Laboratories, Johnson & Johnson, Roche Diagnostics & Siemens Healthcare Dominating",http://www.reuters.com/article/2014/07/22/research-and-markets-idUSnBw225777a+100+BSW20140722,
20140723 8:00AM UTC,"Financial Results, Campaign Launch, and New Steps in Facility Planning - Research Reports on Johnson & Johnson, Merck, AstraZeneca, Novartis and Teva",http://www.reuters.com/article/2014/07/23/bc-analysts-review-idUSnPnbHBZrb+9c+PRN20140723,
20140724 7:32AM UTC,"Research and Markets: Global Oral Hygiene Market 2014-2018: Colgate-Palmolive, GlaxoSmithKline, Johnson & Johnson & Procter & Gamble Dominate the Industry",http://www.reuters.com/article/2014/07/24/research-and-markets-idUSnBw245498a+100+BSW20140724,
20140724 4:43AM UTC,"Research and Markets: Asia Pacific Facial Care Market 2014-2019: Unilever, P&G;, Estee Lauder, L 'Oreal, Kose, Kao and Johnson & Johnson are the Key Vendors",http://www.reuters.com/article/2014/07/24/research-and-markets-idUSnBw245360a+100+BSW20140724,
20140730 9:30AM UTC,"The Zacks Analyst Blog Highlights: Johnson & Johnson, Medtronic, Wright Medical Group, Cardinal Health and WellPoint",http://www.reuters.com/article/2014/07/30/zacks-analyst-blog-idUSnPn4Y766K+91+PRN20140730,
20140731 7:30AM UTC,CircleUp Announces Collaboration with Johnson & Johnson Innovation to Identify Transformative Consumer Companies,http://www.reuters.com/article/2014/07/31/idUSnMKWWpmH9a+1e4+MKW20140731,
20140806 9:45AM UTC,Johnson & Johnson app makes it a snap to help students with United Way,http://www.reuters.com/article/2014/08/06/donateaphoto-app-new-idUSnPn4knJy7+84+PRN20140806,
20140811 9:20AM UTC,"Product Launch, Technical Updates, Clinical Study Results, Completion of Tender Offer, and Financial Result - Research Reports on Medtronic, Covidien, Johnson & Johnson, Merck and Jazz",http://www.reuters.com/article/2014/08/11/bc-analysts-review-idUSnPn3ZF55c+98+PRN20140811,
20140811 9:20AM UTC,"David Defeats Goliath (Again), DECN and Pharma Tech Solutions Awarded Victory Over Johnson & Johnson Lifescan in USPTO Final Ruling",http://www.reuters.com/article/2014/08/11/idUSnMKWtb9vwa+1c0+MKW20140811,
20140821 9:20AM UTC,"Drug Approvals, Clinical Trial Result, and Philanthropic Activity - Research Reports on Johnson & Johnson, Biogen, Amgen, Medtronic and Merck",http://www.reuters.com/article/2014/08/20/bc-ar-idUSnPn87MN45+8c+PRN20140820,
20140827 9:30AM UTC,"The Zacks Analyst Blog Highlights: GlaxoSmithKline, Pfizer, Johnson & Johnson, Allergan and EA Sports",http://www.reuters.com/article/2014/08/26/il-zacks-investment-idUSnPn5xbgJr+82+PRN20140826,
20140828 2:21PM UTC,"Research and Markets: Global Intranasal Drug Delivery Market 2014-2018 with Becton, Dickinson and Company, GSK, Johnson & Johnson, & Novartis Dominating",http://www.reuters.com/article/2014/08/27/research-and-markets-idUSnBw276176a+100+BSW20140827,
20140828 10:30AM UTC,We Are Mesh Survivors: Johnson & Johnson Federal Trial on Pelvic Mesh Devices Begins in West Virginia,http://www.reuters.com/article/2014/08/27/wv-we-are-mesh-survivors-idUSnBw275179a+100+BSW20140827,
20140828 9:00AM UTC,Wellness & Prevention Showcases The Johnson & Johnson Official 7 Minute Workout App to the Connected Heath Summit: Engaging Consumers,http://www.reuters.com/article/2014/08/27/idUSnMKWN9jlGa+1e2+MKW20140827,
20140829 8:30PM UTC,Johnson & Johnson to seek buyer for medical device maker unit: WSJ,http://www.reuters.com/article/2014/08/29/us-johnson-johnson-divestiture-idUSKBN0GT01820140829,
20140829 8:27PM UTC,Johnson & Johnson to seek buyer for medical device maker unit -WSJ,http://www.reuters.com/article/2014/08/29/johnson-johnson-divestiture-idUSL1N0QZ01520140829,
20140829 9:30AM UTC,"Acquisitions, Appointment, and Vaccine Recommendations - Research Reports on InterMune, Amgen, Johnson & Johnson, Merck and Medtronic",http://www.reuters.com/article/2014/08/28/bc-analystsreviewcom-idUSnPn5WlkJ9+92+PRN20140828,
20140829 9:14AM UTC,FDA says Johnson & Johnson recalls some jaw implants,http://www.reuters.com/article/2014/08/28/us-johnson-johnson-recall-idUSKBN0GS1EM20140828,
20140829 9:11AM UTC,UPDATE 1-FDA says Johnson & Johnson recalls some jaw implants,http://www.reuters.com/article/2014/08/28/johnson-johnson-recall-idUSL3N0QY4AS20140828,
20140829 8:17AM UTC,FDA says Johnson & Johnson recalls some jaw implants,http://www.reuters.com/article/2014/08/28/johnson-johnson-recall-idUSL3N0QY48R20140828,
20140830 10:06AM UTC,"Research and Markets: Skin Care Market in Europe 2014-2018: Key Vendors are Beiersdorf, Johnson & Johnson, L'Oreal, Procter & Gamble and Unilever Group",http://www.reuters.com/article/2014/08/29/research-and-markets-idUSnBw295343a+100+BSW20140829,
20140904 7:45AM UTC,Johnson & Johnson to Participate in 2014 Morgan Stanley Health Care Conference,http://www.reuters.com/article/2014/09/03/nj-jj-conference-idUSnPn5Sgsv4+90+PRN20140903,
20140905 12:01AM UTC,Johnson & Johnson Responds to Ebola Crisis With Commitment to Accelerate Vaccine Program in Collaboration With the US National Institutes of Health (NIH) and Provide Humanitarian Relief Aid,http://www.reuters.com/article/2014/09/04/nj-johnson-johnson-idUSnPncfC7By+8a+PRN20140904,
20140906 4:29PM UTC,We Are Mesh Survivors Applauds Verdict against Johnson and Johnson on Pelvic Mesh: Jury Delivers $3.27 Million Verdict for Plaintiff Jo Huskey in Johnson & Johnson Federal Trial on Pelvic Mesh Devices in West Virginia,http://www.reuters.com/article/2014/09/05/wv-we-are-mesh-survivors-idUSnBw055879a+100+BSW20140905,
20140906 9:00AM UTC,"Upcoming Presentations, Technical Update, Study Results, and Marketing Authorization Application - Research Reports on Novartis, InterMune, Johnson & Johnson, Amgen and Merck",http://www.reuters.com/article/2014/09/05/bc-analysts-review-idUSnPnCBkhr+58+PRN20140905,
20140916 9:15AM UTC,"New Product Launch, Accelerated Drug Approvals, Study Initiation, and Market Activity - Research Reports on Johnson & Johnson, Merck, Medtronic, Pharmacyclics and NPS Pharma",http://www.reuters.com/article/2014/09/15/bc-analysts-review-idUSnPn6bksN5+82+PRN20140915,
20140924 2:00PM UTC,Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results,http://www.reuters.com/article/2014/09/23/johnsonjohnson-call-idUSnPn3gwvSF+83+PRN20140923,
20140924 9:05AM UTC,"Regulatory Approval, Presentation of Data, Appointment, Clinical Study Results, and Increase in Quarterly Dividend - Research Reports on Johnson & Johnson, Merck, Medtronic, Amgen and Covidien",http://www.reuters.com/article/2014/09/23/bc-analysts-review-idUSnPn905035+80+PRN20140923,
20140930 9:30AM UTC,"The Zacks Analyst Blog Highlights: Gilead Sciences, Bristol-Myers, Johnson & Johnson, AbbVie and Medivation",http://www.reuters.com/article/2014/09/29/il-zacksinvestment-idUSnPn1tRmk6+88+PRN20140929,
20140930 7:06AM UTC,"Research and Markets: Global Antibiotics Market 2014-2018: AstraZeneca, Eli Lilly, GSK, Johnson & Johnson, Novartis, Pfizer & Sanofi Lead the Market",http://www.reuters.com/article/2014/09/29/research-and-markets-idUSnBw295486a+100+BSW20140929,
20141001 2:48PM UTC,Johnson & Johnson to buy private drug developer for $1.75 billion,http://www.reuters.com/article/2014/09/30/us-aliosbiopharma-m-a-johnson-johnson-idUSKCN0HP1BQ20140930,
20141001 2:39PM UTC,UPDATE 2-Johnson & Johnson to buy private drug developer for $1.75 bln,http://www.reuters.com/article/2014/09/30/aliosbiopharma-ma-johnson-johnson-idUSL3N0RV50P20140930,
20141001 2:21PM UTC,Defective Surgical Product Lawsuits Filed Against Johnson & Johnson,http://www.reuters.com/article/2014/09/30/fl-cohen-milstein-idUSnBw306590a+100+BSW20140930,
20141001 8:50AM UTC,Johnson & Johnson to buy private drug developer for $1.75 bln,http://www.reuters.com/article/2014/09/30/aliosbiopharma-ma-johnson-johnson-idUSL3N0RV4V320140930,
20141001 8:30AM UTC,Johnson & Johnson Announces Agreement To Acquire Alios BioPharma,http://www.reuters.com/article/2014/09/30/johnsonjohnson-alios-idUSnPn53pT0j+84+PRN20140930,
20141001 8:30AM UTC,Alios BioPharma Announces Acquisition Agreement With Johnson & Johnson,http://www.reuters.com/article/2014/09/30/idUSnMKWDTwGBa+1f6+MKW20140930,
20141002 9:10AM UTC,"Legal Settlement, Data Presentation, Welfare Initiatives, Acquisition Talks, and Study Results - Research Reports on Shire, Merck, Medtronic, Salix and Johnson & Johnson",http://www.reuters.com/article/2014/10/01/bc-analysts-review-idUSnPn4tJ7bs+88+PRN20141001,
20141008 12:01AM UTC,"Johnson & Johnson Vision Care Companies Announces Sight For Kids Screens 20 Million Children, Expands To Kenya and Turkey",http://www.reuters.com/article/2014/10/07/jjvcc-sight-for-kids-idUSnPn4PJ1pC+99+PRN20141007,
20141009 11:59AM UTC,SHPE Presents 2014 STAR Award Company of the Year to Johnson & Johnson and Government Agency of the Year to U.S. Army,http://www.reuters.com/article/2014/10/08/ca-shpe-star-awards-idUSnPn4cpbds+80+PRN20141008,
20141014 9:29AM UTC,"Bank of America, Google, Intel, Johnson & Johnson and General Electric are part of Zacks Earnings Preview:",http://www.reuters.com/article/2014/10/13/il-zacksinvestment-idUSnPn2R9DmG+95+PRN20141013,
20141014 8:35AM UTC,"Welfare Initiatives, Clinical Data Presentation, Financing Plan, Regulatory Disclosure, and Positive Drug Trials - Research Reports on Johnson & Johnson, Merck, Medtronic, Covidien and Amgen",http://www.reuters.com/article/2014/10/13/bc-analysts-review-idUSnPn2l93fB+81+PRN20141013,
20141016 9:00AM UTC,Johnson & Johnson Family of Consumer Companies Turns Brands Purple in Support of Spirit Day,http://www.reuters.com/article/2014/10/15/nj-johnsonjohnsonlgbt-idUSnPnbZP75Z+99+PRN20141015,
20141017 8:00AM UTC,Aduro Expands Collaboration with Johnson & Johnson Innovation and Janssen for Lung Cancer Immunotherapies,http://www.reuters.com/article/2014/10/16/ca-aduro-biotech-idUSnBw165133a+100+BSW20141016,
20141017 7:44AM UTC,Johnson & Johnson Announces Quarterly Dividend for Fourth Quarter 2014,http://www.reuters.com/article/2014/10/16/nj-johnsonjohnsondiv-idUSnPn9RMP0m+9c+PRN20141016,
20141021 10:21AM UTC,"Research and Markets: United States Traditional Wound Management Market Outlook 2020 - Leading Vendors are Johnson & Johnson, Medline Industries, Inc. and Covidien plc",http://www.reuters.com/article/2014/10/20/research-and-markets-idUSnBw206014a+100+BSW20141020,
20141021 9:15AM UTC,"Research and Markets: United States Wound Closure Devices Market Outlook 2020: Key Players are Johnson & Johnson, Baxter International & Pfizer",http://www.reuters.com/article/2014/10/20/research-and-markets-idUSnBw205860a+100+BSW20141020,
20141021 8:51AM UTC,"Research and Markets: United Kingdom Wound Closure Devices Market Outlook 2020: Key Vendors are Johnson & Johnson, Baxter International and Pfizer Inc",http://www.reuters.com/article/2014/10/20/research-and-markets-idUSnBw205772a+100+BSW20141020,
20141022 10:23AM UTC,"Research and Markets: United States Surgical Sutures Market Outlook 2020: Key Players are Johnson & Johnson, Covidien plc and B. Braun Melsungen AG",http://www.reuters.com/article/2014/10/21/research-and-markets-idUSnBw216170a+100+BSW20141021,
20141022 9:00AM UTC,"Merger Deal Updates, Dividend, Dispute Settlement, Regulatory Application Submission, and Preliminary Results - Research Reports on Shire, Johnson & Johnson, Merck, Amgen and HCA",http://www.reuters.com/article/2014/10/21/bc-analysts-review-idUSnPn4QXDXb+9e+PRN20141021,
20141022 7:26AM UTC,"Research and Markets: South Korea Surgical Sutures Market Outlook 2020: Key Players are Johnson & Johnson, B. Braun Melsungen AG and Covidien plc",http://www.reuters.com/article/2014/10/21/research-and-markets-idUSnBw215605a+100+BSW20141021,
20141022 7:20AM UTC,"Research and Markets: China Surgical Sutures Market Outlook 2020: Key Players are Johnson & Johnson, Covidien plc and B. Braun Melsungen AG",http://www.reuters.com/article/2014/10/21/research-and-markets-idUSnBw215597a+100+BSW20141021,
20141022 7:09AM UTC,"Research and Markets: United Kingdom Surgical Sutures Market Outlook 2020: Key Players are Johnson & Johnson, Covidien plc and B. Braun Melsungen AG",http://www.reuters.com/article/2014/10/21/research-and-markets-idUSnBw215585a+100+BSW20141021,
20141023 3:18AM UTC,BRIEF-Johnson & Johnson Development Corporation to subscribe for shares in Bavarian Nordic,http://www.reuters.com/article/2014/10/22/bavarian-nordic-brief-idUSFWN0SH00120141022,
20141023 2:02AM UTC,Johnson & Johnson Announces Major Commitment to Speed Ebola Vaccine Development and Significantly Expand Production,http://www.reuters.com/article/2014/10/22/nj-jj-ebola-vaccine-idUSnPnyhK2F+45+PRN20141022,
20141023 1:56AM UTC,REG-Bavarian Nordic Announces Additional Details Concerning the Issue of Shares to Johnson & Johnson Development Corporation,http://www.reuters.com/article/2014/10/22/idUSnHUG5fxbtx+1c0+ONE20141022,
20141024 6:10PM UTC,Johnson & Johnson's DePuy wins first trial over Pinnacle hips,http://www.reuters.com/article/2014/10/23/us-johnson-johnson-trial-verdict-idUSKCN0IC2GH20141023,
20141024 6:09PM UTC,UPDATE 2-Johnson & Johnson's DePuy wins first trial over Pinnacle hips,http://www.reuters.com/article/2014/10/23/johnson-johnson-trial-verdict-idUSL2N0SI2UO20141023,
20141024 4:23PM UTC,Johnson & Johnson's DePuy wins first trial over Pinnacle hips,http://www.reuters.com/article/2014/10/23/johnson-johnson-trial-verdict-idUSL2N0SH37S20141023,
20141029 4:00PM UTC,Johnson & Johnson Innovation Launches Asia Pacific Innovation Center and Announces New Alliances,http://www.reuters.com/article/2014/10/28/jjohnson-innovation-idUSnPn6nY2Gr+8a+PRN20141028,
20141030 11:10PM UTC,INDIA PRESS-Johnson & Johnson may buy electrolyte drink ORS-L for 7 bln rupees - Times of India,http://www.reuters.com/article/2014/10/30/india-press-johnson-johnson-idUSL4N0SP1S020141030,
20141030 5:14AM UTC,REG-Capital Increase in Bavarian Nordic A/S as a Result of Completion of a Direct Placement to Johnson & Johnson Development Corporation,http://www.reuters.com/article/2014/10/29/idUSnHUG1LHbvt+1d8+ONE20141029,
20141031 9:15AM UTC,"Financial Results, Program Expansion, Product Launch, and Share Dealings - Research Reports on Merck, Johnson & Johnson, Amgen, Medtronic and Shire",http://www.reuters.com/article/2014/10/30/bc-analysts-review-idUSnPn4BjdCC+93+PRN20141030,
20141031 9:00AM UTC,Johnson & Johnson Diabetes Solutions Companies Join The Joslin Institute for Technology Translation (JITT) As Founding Members,http://www.reuters.com/article/2014/10/30/ma-joslin-diabetes-idUSnBw305045a+100+BSW20141030,
20141101 6:27AM UTC,"Research and Markets: Australia Surgical Sutures Market Outlook to 2020: Key players covered include Johnson & Johnson, Covidien plc and B. Braun Melsungen AG",http://www.reuters.com/article/2014/10/31/research-and-markets-idUSnBw315201a+100+BSW20141031,
20141101 6:25AM UTC,"Research and Markets: Canada Traditional Wound Management Market Outlook to 2020: Key players covered include Johnson & Johnson, Medline Industries, Inc. and Covidien plc",http://www.reuters.com/article/2014/10/31/research-and-markets-idUSnBw315200a+100+BSW20141031,
20141101 6:09AM UTC,"Research and Markets: Italy Surgical Sutures Market Outlook to 2020: Key Players Covered Include Johnson & Johnson, Covidien plc and B. Braun Melsungen AG.",http://www.reuters.com/article/2014/10/31/research-and-markets-idUSnBw315194a+100+BSW20141031,
20141107 4:01PM UTC,Nurse.com announces special continuing education module on Ebola for nurses in partnership with the Johnson & Johnson Campaign for Nursing's Future,http://www.reuters.com/article/2014/11/06/nursecom-conted-ebol-idUSnPnc8SJtB+8d+PRN20141106,
20141108 4:05PM UTC,Johnson & Johnson Announces Completion Of Alios BioPharma Acquisition,http://www.reuters.com/article/2014/11/07/johnsonjohnsonacquire-idUSnPncgfKPw+86+PRN20141107,
20141108 8:50AM UTC,"Collaboration, Breakthrough Therapy Designation, Clinical Trial Data, Voting Rights, and Financial Results - Research Reports on Johnson & Johnson, Merck, Amgen, Shire and HCA",http://www.reuters.com/article/2014/11/07/bc-analysts-review-idUSnPnkS5cD+49+PRN20141107,
20141108 6:38AM UTC,Johnson & Johnson buys energy drink brand in India,http://www.reuters.com/article/2014/11/07/johnson-johnson-india-idUSL4N0SX5VI20141107,
20141114 5:58AM UTC,BRIEF-Ab-Biotics says signs agreeement with Johnson & Johnson unit on development of probiotic,http://www.reuters.com/article/2014/11/13/ab-bioticssa-brief-idUSFWN0T205I20141113,
20141119 2:39PM UTC,Fitch Rates Johnson & Johnson's Debt Offering 'AAA',http://www.reuters.com/article/2014/11/18/ny-fitch-ratings-jnj-idUSnBw186548a+100+BSW20141118,
20141122 8:50AM UTC,"Research and Markets: Medical Technology Market in Europe 2014-2018: Key Vendors are GE Healthcare, Johnson & Johnson, Medtronic, Roche and Siemens Healthcare",http://www.reuters.com/article/2014/11/21/research-and-markets-idUSnBw215357a+100+BSW20141121,
20141128 6:12AM UTC,"Research and Markets: Russia Wound Care Management Market Outlook to 2020: Key players covered include Johnson & Johnson, Covidien, Medline, BSN, 3M, Coloplast, ConvaTec and Smith & Nephew",http://www.reuters.com/article/2014/11/27/research-and-markets-idUSnBw275117a+100+BSW20141127,
20141128 6:06AM UTC,"Research and Markets: Germany Wound Care Management Market Outlook to 2020: Key Players Covered Include Johnson & Johnson, Covidien, Medline, BSN, 3M, Coloplast, ConvaTec and Smith & Nephew",http://www.reuters.com/article/2014/11/27/research-and-markets-idUSnBw275114a+100+BSW20141127,
20141128 5:58AM UTC,"Research and Markets: South Korea Wound Care Management Market Outlook to 2020: Key Players Covered Include Johnson & Johnson, Covidien, Medline, BSN, 3M, Coloplast, ConvaTec and Smith & Nephew",http://www.reuters.com/article/2014/11/27/research-and-markets-idUSnBw275109a+100+BSW20141127,
20141128 5:50AM UTC,"Research and Markets: France Wound Care Management Market Outlook to 2020: Key Players Covered Include Johnson & Johnson, Covidien, Medline, BSN, 3M, Coloplast, ConvaTec and Smith & Nephew",http://www.reuters.com/article/2014/11/27/research-and-markets-idUSnBw275095a+100+BSW20141127,
20141128 5:36AM UTC,"Research and Markets: India Wound Care Management Market Outlook to 2020: Key Players Covered Include Johnson & Johnson, Covidien, Medline, BSN, 3M, Coloplast, ConvaTec and Smith & Nephew",http://www.reuters.com/article/2014/11/27/research-and-markets-idUSnBw275082a+100+BSW20141127,
20141128 5:26AM UTC,"Research and Markets: Italy Wound Care Management Market Outlook to 2020: Key Players Covered Include Johnson & Johnson, Covidien, Medline, BSN, 3M, Coloplast, ConvaTec and Smith & Nephew",http://www.reuters.com/article/2014/11/27/research-and-markets-idUSnBw275079a+100+BSW20141127,
20141128 5:02AM UTC,"Research and Markets: Spain Wound Care Management Market Outlook to 2020: Key players covered include Johnson & Johnson, Covidien, Medline, BSN, 3M, Coloplast, ConvaTec and Smith & Nephew",http://www.reuters.com/article/2014/11/27/research-and-markets-idUSnBw275071a+100+BSW20141127,
20141128 4:46AM UTC,"Research and Markets: Mexico Wound Care Management Market Outlook to 2020: Key players covered include Johnson & Johnson, Covidien, Medline Industries, BSN, 3M, Coloplast, ConvaTec and Smith & Nephew",http://www.reuters.com/article/2014/11/27/research-and-markets-idUSnBw275062a+100+BSW20141127,
20141128 4:00AM UTC,"Research and Markets: Canada Wound Care Management Market Outlook to 2020: Key players covered include Johnson & Johnson, Covidien, Medline, BSN, 3M, Coloplast, ConvaTec and Smith & Nephew",http://www.reuters.com/article/2014/11/27/research-and-markets-idUSnBw275046a+100+BSW20141127,
20141128 3:58AM UTC,"Research and Markets: Japan Wound Care Management Market Outlook to 2020: Key players covered Johnson & Johnson, Covidien, Medline, BSN Medical, 3M Health Care, Coloplast, ConvaTec and Smith & Nephew",http://www.reuters.com/article/2014/11/27/research-and-markets-idUSnBw275045a+100+BSW20141127,
20141128 2:39AM UTC,BRIEF-IP Group says Johnson & Johnson Innovation and Janssen partnership worth up to 176 mln stg,http://www.reuters.com/article/2014/11/27/ipgroup-brief-idUSFWN0TH00L20141127,
20141129 7:32AM UTC,"Research and Markets: Australia Wound Care Management Market Outlook to 2020: Key players covered include Johnson & Johnson, Covidien, Medline, BSN, 3M, Coloplast, ConvaTec and Smith & Nephew",http://www.reuters.com/article/2014/11/28/research-and-markets-idUSnBw285156a+100+BSW20141128,
20141129 6:07AM UTC,"Research and Markets: United Kingdom Wound Care Management Market Outlook to 2020: Key players covered include Johnson & Johnson, Covidien, Medline, BSN, 3M, Coloplast, ConvaTec and Smith & Nephew",http://www.reuters.com/article/2014/11/28/research-and-markets-idUSnBw285107a+100+BSW20141128,
20141202 4:49PM UTC,"Research and Markets: Asia-Pacific Wound Closure Devices Market Outlook 2014-2020: Key Vendors are Johnson & Johnson, Covidien plc. and Baxter International Inc",http://www.reuters.com/article/2014/12/01/research-and-markets-idUSnBw016460a+100+BSW20141201,
20141202 10:48AM UTC,"Research and Markets: Asia-Pacific Traditional Wound Management Market Outlook to 2020: Key Players Covered Include Medline, Johnson & Johnson and Covidien",http://www.reuters.com/article/2014/12/01/research-and-markets-idUSnBw015854a+100+BSW20141201,
20141203 5:00PM UTC,"Bristol-Myers Squibb Makes $1 Million Investment, Joining Johnson & Johnson to Support Sector Transformation for HIV/AIDS Service Organizations",http://www.reuters.com/article/2014/12/02/idUSnMKWRCwHQa+1f6+MKW20141202,
20141203 8:00AM UTC,"Atreca, Inc., Establishes Strategic Collaboration with Johnson & Johnson Innovation and Janssen to Apply Immune Repertoire Captureâ„¢ Technology to Autoimmune Disease",http://www.reuters.com/article/2014/12/02/ca-atreca-inc-idUSnBw025299a+100+BSW20141202,
20141209 6:02PM UTC,"Research and Markets: North America Traditional Wound Management Market Outlook to 2020 - Key Vendors are Medline Industries, Inc., Johnson & Johnson and Covidien plc",http://www.reuters.com/article/2014/12/08/research-and-markets-idUSnBw086568a+100+BSW20141208,
20141209 8:27AM UTC,"Research and Markets: BRIC Wound Closure Devices Market Outlook to 2020: Key players covered include Johnson & Johnson, Covidien and Baxter International",http://www.reuters.com/article/2014/12/08/research-and-markets-idUSnBw085608a+100+BSW20141208,
20141209 8:10AM UTC,"Research and Markets: EU5 Wound Closure Devices Market Outlook to 2020: Key players covered include Johnson & Johnson, Covidien and Baxter International",http://www.reuters.com/article/2014/12/08/research-and-markets-idUSnBw085574a+100+BSW20141208,
20141210 5:20AM UTC,"Research and Markets: Asia-Pacific Surgical Sutures Market Outlook to 2020: Key Players Covered Include Johnson & Johnson, Sutures India Private Limited and Covidien",http://www.reuters.com/article/2014/12/09/research-and-markets-idUSnBw095417a+100+BSW20141209,
20141211 1:00PM UTC,"BP Logix Customer, Johnson & Johnson, Selected As Winner In Gartner Business Process Management Excellence Awards 2014",http://www.reuters.com/article/2014/12/10/bp-logix-winner-idUSnPn709BxP+85+PRN20141210,
20141211 9:37AM UTC,"Research and Markets: BRIC Traditional Wound Management Market Outlook to 2020: Key players covered include Medline, Johnson & Johnson and Covidien",http://www.reuters.com/article/2014/12/10/research-and-markets-idUSnBw105805a+100+BSW20141210,
20141211 9:08AM UTC,"Research and Markets: EU5 Surgical Sutures Market Outlook to 2020: Key players covered include Johnson & Johnson, B. Braun Melsungen and Covidien",http://www.reuters.com/article/2014/12/10/research-and-markets-idUSnBw105745a+100+BSW20141210,
20141211 8:23AM UTC,"Research and Markets: BRIC Surgical Sutures Market Outlook to 2020: Key players covered include Johnson & Johnson, Sutures India Private Limited and Covidien",http://www.reuters.com/article/2014/12/10/research-and-markets-idUSnBw105636a+100+BSW20141210,
20141211 7:00AM UTC,HeartFlow Appoints Former Johnson & Johnson Chairman and CEO William C. Weldon to Board of Directors,http://www.reuters.com/article/2014/12/10/ca-heartflow-idUSnBw105201a+100+BSW20141210,
20141212 4:30PM UTC,Johnson & Johnson Announces Collaboration between Janssen and USAID to Expand Access to Anti-Multidrug-Resistant Tuberculosis (MDR-TB) Compound,http://www.reuters.com/article/2014/12/11/johnsonjohnson-mou-idUSnPn2J982m+90+PRN20141211,
20141217 8:38AM UTC,"Research and Markets: Global Chemical Sensor Market 2015-2019: Key Vendors are Abbott Laboratories, Bayer, Hoffmann La-Roche, Johnson & Johnson, NGK Spark Plugs and Robert Bosch",http://www.reuters.com/article/2014/12/16/research-and-markets-idUSnBw165659a+100+BSW20141216,
20141217 5:42AM UTC,"Research and Markets: Canada Surgical Sutures Market Outlook to 2020: Key Players Covered Include Johnson & Johnson, Covidien plc and B. Braun Melsungen AG",http://www.reuters.com/article/2014/12/16/research-and-markets-idUSnBw165373a+100+BSW20141216,
20141217 5:05AM UTC,"Research and Markets: France Surgical Sutures Market Outlook to 2020: Key players covered include Johnson & Johnson, Covidien plc and B. Braun Melsungen AG",http://www.reuters.com/article/2014/12/16/research-and-markets-idUSnBw165350a+100+BSW20141216,
20141218 10:00AM UTC,Johnson & Johnson to Host Fourth-Quarter/Full-Year 2014 Investor Conference Call on Results,http://www.reuters.com/article/2014/12/17/nj-jj-q4-conf-call-idUSnPn99Cx4p+88+PRN20141217,
20141218 7:29AM UTC,"Research and Markets: India Surgical Sutures Market Outlook to 2020: Key players covered include Johnson & Johnson, Covidien and Sutures India Private",http://www.reuters.com/article/2014/12/17/research-and-markets-idUSnBw175431a+100+BSW20141217,
20141218 7:21AM UTC,"Research and Markets: Japan Surgical Sutures Market Outlook to 2020: Key Players Covered Include Johnson & Johnson, Gunze Limited and Alfresa Pharma Corporation",http://www.reuters.com/article/2014/12/17/research-and-markets-idUSnBw175429a+100+BSW20141217,
20141220 9:14AM UTC,"Research and Markets: Russia Surgical Sutures Market Outlook to 2020: Key Players Covered Include Johnson & Johnson, B. Braun Melsungen and Covidien",http://www.reuters.com/article/2014/12/19/research-and-markets-idUSnBw195485a+100+BSW20141219,
20141220 7:58AM UTC,"Research and Markets: Spain Surgical Sutures Market Outlook to 2020: Key players covered include Johnson & Johnson, B. Braun Melsungen and Covidien",http://www.reuters.com/article/2014/12/19/research-and-markets-idUSnBw195357a+100+BSW20141219,
20141220 7:25AM UTC,"Research and Markets: Mexico Surgical Sutures Market Outlook to 2020: Key Players Covered Include Johnson & Johnson, Atramat and Covidien",http://www.reuters.com/article/2014/12/19/research-and-markets-idUSnBw195306a+100+BSW20141219,
20141220 7:19AM UTC,"Research and Markets: Brazil Surgical Sutures Market Outlook to 2020: Key Players Covered Include Johnson & Johnson, Covidien and B. Braun Melsungen",http://www.reuters.com/article/2014/12/19/research-and-markets-idUSnBw195299a+100+BSW20141219,
20141223 6:30AM UTC,Sevion Announces Antibody Discovery Collaboration with Johnson & Johnson Innovation and Janssen,http://www.reuters.com/article/2014/12/22/ca-sevion-therapeutics-idUSnBw225040a+100+BSW20141222,
20141231 8:45AM UTC,Johnson & Johnson to Participate in 33rd Annual JP Morgan Health Care Conference,http://www.reuters.com/article/2014/12/30/johnsonjohnson-jpmorg-idUSnPnblKbjs+88+PRN20141230,
20150106 8:45AM UTC,Johnson & Johnson Announces Quarterly Dividend for First Quarter 2015,http://www.reuters.com/article/2015/01/05/johnsonjohnson-div-idUSnPn1m8Tt4+84+PRN20150105,
20150107 2:00AM UTC,Johnson & Johnson Announces Start of Phase 1 Clinical Trial of Ebola Vaccine Regimen,http://www.reuters.com/article/2015/01/06/jj-ebolavaccinetrial-idUSnPn12NhpS+89+PRN20150106,
20150110 8:15AM UTC,X-Chem Announces Collaboration with Janssen and Johnson & Johnson Innovation to Advance Novel Candidates to Treat Inflammatory Diseases,http://www.reuters.com/article/2015/01/09/ma-x-chem-idUSnBw095077a+100+BSW20150109,
20150113 8:30AM UTC,"MaRS Innovation Announces Collaboration with Johnson & Johnson Innovation and Janssen to Advance Cardiac, Diabetes and Depression Technologies",http://www.reuters.com/article/2015/01/12/mars-collaboration-idUSnPn4mLZvn+8c+PRN20150112,
20150114 8:00AM UTC,Janssen and Johnson & Johnson Innovation Announce License Agreement with Vedanta Biosciences for Microbiome Pharmaceutical Candidate for Inflammatory Bowel Disease,http://www.reuters.com/article/2015/01/13/ma-johnson-johnson-idUSnBw135475a+100+BSW20150113,
20150116 5:40AM UTC,"Research and Markets: Global Acute Myeloid Leukemia Therapeutics Market 2015-2019 With Bristol Myers Squibb, Celgene, Johnson & Johnson & Pfizer Dominating",http://www.reuters.com/article/2015/01/15/research-and-markets-idUSnBw155287a+100+BSW20150115,
20150117 6:29AM UTC,"Johnson & Johnson Announces Formation of Ebola Vaccine Development Consortia, Gains Funding from Innovative Medicines Initiative",http://www.reuters.com/article/2015/01/16/nj-jnj-ebola-vaccine-idUSnPn6N1Jgv+94+PRN20150116,
20150120 7:30AM UTC,"Latest Buzz on the Street: Exclusive Reports on Comerica, Johnson & Johnson, Schlumberger, Monsanto, and Courier",http://www.reuters.com/article/2015/01/19/bc-analysts-review-idUSnPn3c4Vvm+84+PRN20150119,
20150121 6:09PM UTC,Johnson & Johnson's forex warning a sign for rival drugmakers,http://www.reuters.com/article/2015/01/20/us-johnson-johnson-results-currency-idUSKBN0KT2KQ20150120,
20150121 6:06PM UTC,Johnson & Johnson's forex warning a sign for rival drugmakers,http://www.reuters.com/article/2015/01/20/johnsonjohnson-results-currency-idUSL1N0UZ20P20150120,
20150121 7:45AM UTC,Johnson & Johnson Reports 2014 Fourth-Quarter and Full-Year Results:,http://www.reuters.com/article/2015/01/20/nj-johnson-q4-earns-idUSnPn9L2HvD+95+PRN20150120,
20150122 7:39PM UTC,Johnson & Johnson's $7.2 billion claim against Boston Scientific now with U.S. judge,http://www.reuters.com/article/2015/01/22/us-johnson-johnson-boston-scient-trial-idUSKBN0KV01N20150122,
20150123 7:20AM UTC,"Research and Markets: Asia Pacific Medical Technologies Market Report 2015-2019 with BD, GE Healthcare, Johnson & Johnson, Medtronic, Roche Diagnostics & Siemens Healthcare Diagnostics Dominating",http://www.reuters.com/article/2015/01/22/research-and-markets-idUSnBw225422a+100+BSW20150122,
20150129 8:30AM UTC,Applied Molecular Transport Announces Research and Development Collaboration with Janssen and Johnson & Johnson Innovation for Novel Therapeutic Candidate to Treat Inflammatory Bowel Diseases,http://www.reuters.com/article/2015/01/28/applied-molecular-idUSnPnb1Y17n+88+PRN20150128,
20150130 6:02AM UTC,"Global Multiple Myeloma Drugs Market 2015-2019: Key Vendors are Celgene, Johnson & Johnson, Novartis, Onyx Pharmaceuticals, Sanofi and Takeda Pharmaceutical",http://www.reuters.com/article/2015/01/29/idUSnGNX864h9W+1c1+GNW20150129,
20150206 9:00AM UTC,Johnson & Johnson Chief Procurement Officer Named as ISM Board Chair,http://www.reuters.com/article/2015/02/05/az-ism-hans-melotte-idUSnPn9l07n3+80+PRN20150205,
20150213 2:34PM UTC,Johnson & Johnson Announces Patent and Trademark Office Action Related to REMICADEÂ®,http://www.reuters.com/article/2015/02/12/jnj-patent-remicade-idUSnPn9JhZl+4a+PRN20150212,
20150217 1:03PM UTC,Johnson & Johnson Selects Rutgers to Drive Digital Transformation,http://www.reuters.com/article/2015/02/16/rutgers-exec-programs-idUSnPn86BH7B+8d+PRN20150216,
20150218 4:05PM UTC,Boston Scientific Announces Agreement With Johnson & Johnson To Resolve Guidant Litigation,http://www.reuters.com/article/2015/02/17/boston-scientific-jj-idUSnPn212K14+84+PRN20150217,
20150227 8:00AM UTC,Johnson & Johnson Tops IDEA Pharma's Productive Innovation Index for the Third Consecutive Year,http://www.reuters.com/article/2015/02/26/bc-productive-innovation-idUSnPn86wcsJ+81+PRN20150226,
20150227 8:00AM UTC,Johnson & Johnson Announces Formation of New Health and Wellness Platform Designed to Transform Health Care Delivery and Improve the Patient Experience,http://www.reuters.com/article/2015/02/26/johnsonjohnson-new-idUSnPn4pmykJ+81+PRN20150226,
20150227 5:18AM UTC,South Carolina court orders Johnson & Johnson to pay $136 million in Risperdal case,http://www.reuters.com/article/2015/02/26/us-johnson-johnson-risperdal-lawsuit-idUSKBN0LU0YM20150226,
20150303 7:30AM UTC,Johnson & Johnson Announces Binding Offer from Cardinal Health to Acquire Cordis,http://www.reuters.com/article/2015/03/02/jnjcardinalhealth-idUSnPncd88Qf+82+PRN20150302,
20150304 8:00AM UTC,Johnson & Johnson Innovation Opens JLABS @South San Francisco and Announces First Five Resident Startups,http://www.reuters.com/article/2015/03/03/johnson-johnson-idUSnPn36bZB0+86+PRN20150303,
20150306 4:15PM UTC,Johnson & Johnson ordered to pay $5.7 million in California mesh trial,http://www.reuters.com/article/2015/03/05/us-johnson-johnson-mesh-verdict-idUSKBN0M12CF20150305,
20150306 4:11PM UTC,Johnson & Johnson ordered to pay $5.7 mln in California mesh trial,http://www.reuters.com/article/2015/03/05/johnson-johnson-mesh-verdict-idUSL1N0W72E020150305,
20150306 4:04PM UTC,UPDATE 2-Johnson & Johnson ordered to pay $5.7 mln in California mesh trial,http://www.reuters.com/article/2015/03/05/johnson-johnson-mesh-verdict-idUSL1N0W728U20150305,
20150306 3:05PM UTC,CORRECTED-Johnson & Johnson ordered to pay $5.6 mln in California mesh trial,http://www.reuters.com/article/2015/03/05/johnson-johnson-mesh-verdict-idUSL1N0W727I20150305,
20150311 7:19AM UTC,"Research and Markets: Global Baby Wipes Market 2015-2019 with Johnson & Johnson, Kimberly-Clark, Procter & Gamble & Unicharm Dominating",http://www.reuters.com/article/2015/03/10/research-and-markets-idUSnBw105595a+100+BSW20150310,
20150313 6:58PM UTC,Johnson & Johnson sues Glaxo over allergy ads as spring nears,http://www.reuters.com/article/2015/03/12/johnson-johnson-gsk-allergy-idUSL1N0WE3AA20150312,
20150313 6:38PM UTC,Johnson & Johnson sues Glaxo over allergy ads as spring nears,http://www.reuters.com/article/2015/03/12/us-johnson-johnson-gsk-allergy-idUSKBN0M82SN20150312,
20150313 6:35PM UTC,Johnson & Johnson sues Glaxo over allergy ads as spring nears,http://www.reuters.com/article/2015/03/12/johnson-johnson-gsk-allergy-idUSL1N0WE2UT20150312,
20150331 3:54PM UTC,Fitch Affirms Johnson & Johnson's 'AAA' Rating; Outlook Stable,http://www.reuters.com/article/2015/03/30/ny-fitch-ratings-jnj-idUSnBw306329a+100+BSW20150330,
20150331 5:48AM UTC,"Research and Markets: United Kingdom Baby Toiletries Market 2015-2019 with Johnson & Johnson, Kimberly-Clark & Procter & Gamble Dominating",http://www.reuters.com/article/2015/03/30/research-and-markets-idUSnBw305344a+100+BSW20150330,
20150331 5:18AM UTC,"Research and Markets: Global Crohn's Disease (CD) Market 2015-2019: Key Players are AbbVie, Astra Zeneca, Biogen Idec, Johnson & Johnson, Takeda Pharmaceutical & UCB",http://www.reuters.com/article/2015/03/30/research-and-markets-idUSnBw305322a+100+BSW20150330,
20151015 8:55AM UTC,"OICR, UHN, Novera Therapeutics Announce Collaboration with Johnson & Johnson Innovation on Drug Discovery and Development for Haematological Cancers",http://www.reuters.com/article/oicr-novera-facit-idUSnPn9307QY+83+PRN20151014,
20151015 8:00AM UTC,enGene announces strategic collaboration with Johnson & Johnson innovation to develop novel gene delivery products for inflammatory bowel disease,http://www.reuters.com/article/engene-janssen-ibd-idUSnPn4Vsfqv+90+PRN20151014,
20151208 9:52AM UTC,"Robert G. Urban, PhD, Head of Johnson & Johnson Innovation, Boston, and Hala Mirza, Vice President, Corporate Communications, Regeneron, Join NewYorkBIO Board of Directors",http://www.reuters.com/article/ny-newyorkbio-idUSnBw075872a+100+BSW20151207,
20150317 7:22PM UTC,Reserve Officers Association Nathan Hale Awards go to Johnson & Johnson and Huntington Ingalls Industries,http://www.reuters.com/article/2015/03/16/the-reserve-officers-idUSnPnbbcn8Q+81+PRN20150316,
20150318 11:26AM UTC,Johnson & Johnson to Host Investor Conference Call on First-Quarter Results,http://www.reuters.com/article/2015/03/17/johnsonjohnson-call-idUSnPn7l8wtm+80+PRN20150317,
20150318 4:15AM UTC,Johnson & Johnson Announces Strategic Investment Alliance to Combat Dementia Globally,http://www.reuters.com/article/2015/03/17/johnsonjohnson-fund-idUSnPnQWlR9+5a+PRN20150317,
20150324 2:58PM UTC,"Research and Markets: Global Baby Diaper Rash Cream Market 2015-2019 with Chicco USA, Johnson & Johnson, Sebapharma & Summer Laboratories Dominating",http://www.reuters.com/article/2015/03/23/research-and-markets-idUSnBw236298a+100+BSW20150323,
20150327 9:15AM UTC,Johnson & Johnson Vision Care Companies Launches New Beauty Innovation,http://www.reuters.com/article/2015/03/26/johnson-vision-care-idUSnPncqccP+41+PRN20150326,
20150328 8:00AM UTC,Johnson & Johnson to Webcast Annual Meeting of Shareholders,http://www.reuters.com/article/2015/03/27/johnsonjohnsonwebcast-idUSnPncf68xp+80+PRN20150327,
20150401 1:52PM UTC,"Research and Markets: Global Baby Oil Market 2015-2019 with Chicco USA, Johnson & Johnson & Pigeon Dominating",http://www.reuters.com/article/2015/03/31/research-and-markets-idUSnBw316537a+100+BSW20150331,
20150401 9:20AM UTC,Johnson & Johnson Division Attempts Final Appeal in Effort to Overturn Multiple USPTO Decisions Issued in DECN's Favor,http://www.reuters.com/article/2015/03/31/idUSnMKWyY20ta+1d0+MKW20150331,
20150414 8:00AM UTC,Ichor Medical Systems Announces Strategic Collaboration with Johnson & Johnson Innovation to Develop and Commercialize Immunotherapies Delivered with TriGrid Electroporation Device for Chronic Hepatitis B,http://www.reuters.com/article/ca-ichor-medical-idUSnBw135077a+100+BSW20150413,
20150415 9:20AM UTC,U.S. Solicitor General Intervenes Against Johnson & Johnson in DECN's Long Running Patent Battle Over GenStrip 50,http://www.reuters.com/article/2015/04/14/idUSnMKWcnRcga+1c8+MKW20150414,
20150415 7:45AM UTC,Johnson & Johnson Reports 2015 First-Quarter Results:,http://www.reuters.com/article/2015/04/14/johnsonjohnson-earns-idUSnPn4w3DCj+86+PRN20150414,
20150417 9:55AM UTC,BRIEF-Genmab reach $10 mln milestone in Johnson & Johnson collaboration,http://www.reuters.com/article/2015/04/16/genmab-milestone-idUSFWN0XD02F20150416,
20150422 9:15AM UTC,Decision Diagnostics Shrugs Off New Attack As Johnson & Johnson Panics In Patent Case,http://www.reuters.com/article/2015/04/21/decn-patent-case-idUSnPn7yhvpT+81+PRN20150421,
20150424 10:59AM UTC,Johnson & Johnson Announces Dividend Increase of 7.1%,http://www.reuters.com/article/2015/04/23/johnson-johnson-div-idUSnPn2Jb8Kw+92+PRN20150423,
20150430 4:34PM UTC,Johnson & Johnson Announces Further Patent and Trademark Office Action Related to REMICADEÂ®,http://www.reuters.com/article/2015/04/29/johnsonjohnson-idUSnPn7BDP9p+9c+PRN20150429,
20150501 9:00AM UTC,Johnson & Johnson to Participate in the 2015 Deutsche Bank 40th Annual Health Care Conference,http://www.reuters.com/article/2015/04/30/johnsonjohnson-call-idUSnPn2fpWRq+86+PRN20150430,
20150508 12:01AM UTC,Johnson & Johnson Announces NYU School of Medicine Partnership To Evaluate Compassionate Use of Investigational Medicines,http://www.reuters.com/article/2015/05/07/johnson-johnson-nyu-idUSnPn8qkT43+84+PRN20150507,
20150512 8:00AM UTC,Johnson & Johnson Expands IP Policy to Create Broad Access in 128 Countries for Development of New and Optimized HIV Medicine Formulations for Children Living with HIV,http://www.reuters.com/article/2015/05/11/nj-johnson-child-hiv-idUSnPn3VG8Kc+9a+PRN20150511,
20150512 6:00AM UTC,"Operation Smile to Honor Johnson & Johnson Chairman & CEO Alex Gorsky, Philanthropist Barbara Majeski and More at 13th Annual Smile Event",http://www.reuters.com/article/2015/05/11/operation-smile-event-idUSnPn8pDgcv+88+PRN20150511,
20150519 3:43PM UTC,Johnson & Johnson Commits $25 Million to Operation Smile Over Next Five Years,http://www.reuters.com/article/2015/05/18/operation-smile-jj-idUSnPn9TGd4F+99+PRN20150518,
20150520 9:20AM UTC,Decision Diagnostics States Johnson & Johnson Division Offers Partial Surrender in Long Running Patent Battle,http://www.reuters.com/article/2015/05/19/decn-patent-jj-idUSnPn8p4523+80+PRN20150519,
20150521 7:30AM UTC,"Johnson & Johnson Pharmaceutical Segment to Continue Driving Above-Industry Growth with Plans to File More than 10 New Products by 2019, Each with Potential to Exceed $1 Billion in Revenue",http://www.reuters.com/article/2015/05/20/johnsonjohnson-pharm-idUSnPn2HvpXx+92+PRN20150520,
20150522 6:21AM UTC,"Research and Markets: The Analyst's Perspective - April 2015 Issue: Roche's acquisition of CAPP Diagnostics, IBM's announcements of deals with Apple, Johnson & Johnson, and Medtronic & DuPont's acquisition of Taxon Bioscienc",http://www.reuters.com/article/2015/05/21/research-and-markets-idUSnBw215562a+100+BSW20150521,
20150528 10:00AM UTC,"Johnson & Johnson Health and Wellness Solutions Study Shows Tipping Age"" for Health Decline in Adults""",http://www.reuters.com/article/2015/05/27/johnson-johnson-idUSnPn8hvdDM+83+PRN20150527,
20150528 9:30AM UTC,Johnson & Johnson to Participate in the Goldman Sachs 36th Annual Global Healthcare Conference,http://www.reuters.com/article/2015/05/27/jj-goldman-sachs-con-idUSnPn3Ly46d+90+PRN20150527,
20150529 4:10PM UTC,PDA Announces Support for the Johnson & Johnson Kilmer Conference,http://www.reuters.com/article/2015/05/28/pda-jj-kilmer-conf-idUSnPn58hrGp+82+PRN20150528,
20150529 8:00AM UTC,Johnson & Johnson Announces Acceptance of Binding Offer From Cardinal Health To Acquire Cordis,http://www.reuters.com/article/2015/05/28/nj-jnj-acquire-cordis-idUSnPn6nzRhZ+85+PRN20150528,
20150610 4:30PM UTC,CEO and Director of Huntsman Cancer Institute Dr. Mary Beckerle Joins Johnson & Johnson Board of Directors,http://www.reuters.com/article/2015/06/09/johnsonjohnson-elect-idUSnPn9VDqCW+9b+PRN20150609,
20150610 9:00AM UTC,Johnson & Johnson Announces Open Translational Science Project in Schizophrenia,http://www.reuters.com/article/2015/06/09/nj-johnson-johnson-idUSnPn60w90J+81+PRN20150609,
20150612 8:10AM UTC,Arcturus Therapeutics Announces Strategic Collaboration with Johnson & Johnson Innovation to Discover and Develop RNA Medicines for Defined Indications,http://www.reuters.com/article/2015/06/11/arcturus-therapeutics-idUSnPn1HBtH5+9a+PRN20150611,
20150612 8:00AM UTC,BRIM Biotechnology Announces Strategic Collaboration with Johnson & Johnson Innovation to Advance New Treatments for Dengue,http://www.reuters.com/article/2015/06/11/brim-partners-janssen-idUSnPn9McJjB+95+PRN20150611,
20150612 8:00AM UTC,Johnson & Johnson Innovation Announces 17 Collaborations With Focus on Advancing Global Healthcare Through Transformational Science and Technologies,http://www.reuters.com/article/2015/06/11/johnsonjohnson-collab-idUSnPn5zTfxp+88+PRN20150611,
20150612 8:00AM UTC,Carna Biosciences Announces Collaboration With Johnson & Johnson Innovation,http://www.reuters.com/article/2015/06/11/ca-carna-biosciences-idUSnBw115098a+100+BSW20150611,
20150615 8:21PM UTC,"Research and Markets: Baby Care Market in India 2015 Report: Johnson & Johnson, Kimberly-Clark, Procter & Gamble, and Unilever Dominates the Market",http://www.reuters.com/article/2015/06/15/research-and-markets-idUSnBw145106a+100+BSW20150615,
20150617 4:07PM UTC,Johnson & Johnson to Host Investor Conference Call on Second-Quarter Results,http://www.reuters.com/article/2015/06/16/nj-johnson-johnson-idUSnPn6ck3Fr+82+PRN20150616,
20150619 6:11PM UTC,New Jersey's Hart and Celgene and Johnson & Johnson Executives Named toÂ Scientific AmericanÂ WorldviewÂ 100 Most Influential People in Biotechnology,http://www.reuters.com/article/2015/06/18/nj-bionj-idUSnBw186442a+100+BSW20150618,
20150619 7:00AM UTC,Emulate Announces Strategic Collaboration with Johnson & Johnson Innovation to Use Organs-on-Chips Platform to Better Predict Human Response in Drug Development Process,http://www.reuters.com/article/2015/06/18/ma-emulate-idUSnBw185379a+100+BSW20150618,
20150623 4:21PM UTC,MDL sought for Johnson & Johnson power morcellator lawsuits,http://www.reuters.com/article/2015/06/22/products-morcellator-mdl-idUSL1N0Z821A20150622,
20150625 8:30AM UTC,"Johnson & Johnson Vision Care, Inc. Introduces 1-DAY ACUVUEÂ® MOIST Brand MULTIFOCAL Contact Lenses",http://www.reuters.com/article/2015/06/24/jj-vision-lenses-new-idUSnPn4RbNkM+95+PRN20150624,
20150708 11:13AM UTC,"Research and Markets: Global Baby Health and Personal Care Market 2015-2019 with Johnson & Johnson, Kimberly-Clark, Nestle & Procter & Gamble Dominating",http://www.reuters.com/article/research-and-markets-idUSnBw076138a+100+BSW20150707,
20150711 6:11AM UTC,"REFILE-BRIEF-Pharmstandart, Johnson & Johnson sign agreement for LifeScan production in Russia",http://www.reuters.com/article/idUSL8N0ZQ1LM20150710,
20150715 12:45PM UTC,"Johnson & Johnson second-quarter sales wilt on strong dollar, weak device sales",http://www.reuters.com/article/us-johnson-johnson-results-idUSKCN0PO1E920150714,
20150715 7:45AM UTC,Johnson & Johnson Reports 2015 Second-Quarter Results:,http://www.reuters.com/article/johnsonjohnson-earns-idUSnPn32HMzc+8c+PRN20150714,
20150721 11:40AM UTC,Johnson & Johnson Announces Quarterly Dividend for Third Quarter 2015,http://www.reuters.com/article/johnsonjohnson-div-idUSnPn45Qlm6+88+PRN20150720,
20150722 9:00AM UTC,"GreatCall, Higi, Johnson & Johnson, Livongo Health, Lumiata, mPulse Mobile, and Walgreens to Discuss Digital Health Engagement Strategies at Connected Health Summit",http://www.reuters.com/article/idUSnMKWx4Skma+1c8+MKW20150721,
20150807 7:06AM UTC,"Research and Markets: Global Carotid Stent Market 2015 Report: Abbott Vascular, Boston Scientific, Cordis (Johnson & Johnson), and Medtronic Dominate the Market",http://www.reuters.com/article/research-and-markets-idUSnBw065648a+100+BSW20150806,
20150808 10:30AM UTC,Johnson & Johnson gets partial win in patent appeal against Covidien,http://www.reuters.com/article/ethicon-covidien-appeal-idUSL5N10I2VZ20150807,
20150812 10:38AM UTC,BlueLine to Present with Johnson & Johnson IT Executive at Gartner Symposium/ITxpo 2015,http://www.reuters.com/article/blueline-to-present-idUSnPn9hYHmv+8c+PRN20150811,
20150813 3:05AM UTC,Johnson & Johnson Innovation Announces Collaboration on Immuno-Oncology Antibody ADC-1013 with Alligator Bioscience,http://www.reuters.com/article/janssen-collaboration-idUSnPnc03j1z+80+PRN20150812,
20150826 12:57PM UTC,Heartland Food Products Group Enters Definitive Agreement to Acquire SplendaÂ® Brand from Johnson & Johnson Consumer Inc.,http://www.reuters.com/article/heartlandfood-splenda-idUSnPn747Pp1+84+PRN20150825,
20150828 5:29PM UTC,Johnson & Johnson to Participate in the 2015 Wells Fargo 10th Annual Healthcare Conference,http://www.reuters.com/article/johnsonjohnson-conf-idUSnPnlyyGk+42+PRN20150827,
20150903 12:13PM UTC,EBD Group to announce the Johnson & Johnson Innovation Startup Day competition grand prize winner at BioPharm Americaâ„¢ 2015 Partnering Event,http://www.reuters.com/article/ca-ebd-group-event-idUSnPn7HMR42+9c+PRN20150902,
20150904 9:00AM UTC,Johnson & Johnson to Participate in the 2015 Morgan Stanley Healthcare Conference,http://www.reuters.com/article/johnson-johnson-conf-idUSnPnDDldt+58+PRN20150903,
20150911 4:32PM UTC,"Appeal of Conscience Foundation to Honor Alex Gorsky, Chief Executive Officer of Johnson & Johnson, with 2015 Appeal of Conscience Award",http://www.reuters.com/article/appealconcious-awd-idUSnPn74BdMf+8a+PRN20150910,
20150916 6:14PM UTC,Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results,http://www.reuters.com/article/johnsonjohnson-conf-idUSnPnc1RfG2+8a+PRN20150915,
20150917 6:01PM UTC,Best of Boston biotech startups win recognition at BioPharm Americaâ„¢ 2015 during Johnson & Johnson Innovation Startup Day competition,http://www.reuters.com/article/ebd-group-idUSnPn1SC9qz+98+PRN20150916,
20150918 6:15AM UTC,"Research and Markets: Global Implantable Medical Devices Market 2015 Report with - Allergan, Johnson & Johnson, Nobel Biocare, Straumann, and Stryker Dominating",http://www.reuters.com/article/research-and-markets-idUSnBw175540a+100+BSW20150917,
20150922 5:15AM UTC,Nextera AS Announces Research Collaboration with Johnson & Johnson Innovation,http://www.reuters.com/article/nextera-idUSnBw215528a+100+BSW20150921,
20150923 8:45AM UTC,"Technical Data on Healthcare Stocks - Infinity Pharmaceuticals, Boston Scientific, Johnson & Johnson, Mallinckrodt and Eli Lilly",http://www.reuters.com/article/bc-aci-association-idUSnPnbCfqjM+91+PRN20150922,
20150924 9:10AM UTC,"Risperdal Litigation Pioneer Stephen Sheller Featured in DocuSerial"" about Johnson & Johnson"," ""America's Most Admired Lawbreaker"" by Steve Brill""",http://www.reuters.com/article/sheller-docuserial-idUSnPn4zQdjr+88+PRN20150923
20150926 4:15PM UTC,Johnson & Johnson Consumer Inc. Announces Completion of the Divestiture of SPLENDAÂ® Brand to Heartland Food Products Group,http://www.reuters.com/article/johnson-splenda-sale-idUSnPnb7KVzd+8c+PRN20150925,
20150926 4:15PM UTC,"Heartland Consumer Products, LLC Announces the Completion of the Purchase of SPLENDAÂ® Brand from Johnson & Johnson Consumer, Inc.",http://www.reuters.com/article/heartland-splenda-idUSnPn6bkSjw+84+PRN20150925,
20150926 9:34AM UTC,"Appeal of Conscience Foundation Honors Prime Minister David Cameron With World Statesman Award, Laurence Fink, Chairman and Chief Executive Officer of BlackRock and Alex Gorsky, Chief Executive Officer of Johnson & Johnson R",http://www.reuters.com/article/appealofconscience-idUSnPn1G5n9G+91+PRN20150925,
20150930 8:51PM UTC,"Alex Gorsky, CEO of Johnson & Johnson, Joins the National Society of Hispanic MBAs at its 2015 NSHMBA Conference & Career Expo to Speak about Leadership",http://www.reuters.com/article/nshmba-expo-keynote-idUSnPn9xNZgr+8c+PRN20150930,
20150930 9:00AM UTC,"UbiVac Announces Collaboration with Johnson & Johnson Innovation to Develop and Test, in Preclinical Studies, a Vaccine to Intercept Oral Cancer",http://www.reuters.com/article/ubivac-vaccinetrials-idUSnPn5fqPrC+85+PRN20150929,
20151002 10:19AM UTC,Johnson & Johnson Consumer Inc.'s Care To Recycle Program and Scholastic Launch Nationwide Educational Campaign and Contest,http://www.reuters.com/article/johnsonjohnson-idUSnPn2dgsvl+80+PRN20151001,
20151003 4:38AM UTC,"Research and Markets: Global Medical Device Market 2015-2020: Trend, Profit and Forecast Analysis Featuring Johnson & Johnson, Medtronic Plc., Siemens Ltd, General Electric Co., and Baxter International",http://www.reuters.com/article/research-and-markets-idUSnBw025205a+100+BSW20151002,
20151005 7:00PM UTC,Johnson & Johnson Announces Completion of Cordis Divestiture to Cardinal Health,http://www.reuters.com/article/johnsonjohnson-sell-idUSnPn6V23bf+90+PRN20151004,
20151007 5:20AM UTC,"Research and Markets: Global Energy-Based Therapeutics Market - Industry Analysis 2015-2019: Key Vendors Are Johnson & Johnson, Lumenis & Syneron Medical",http://www.reuters.com/article/research-and-markets-idUSnBw065863a+100+BSW20151006,
20151010 2:00AM UTC,Johnson & Johnson Announces Start of Clinical Trial of Ebola Vaccine Regimen in Sierra Leone,http://www.reuters.com/article/jnj-ebola-clin-trial-idUSnPn1QpQ2+4a+PRN20151009,
20151013 9:00AM UTC,"Out & Equal Honors Johnson & Johnson, The Dow Chemical Company and The Walt Disney Company at 2015 Out & Equal Workplace Summit",http://www.reuters.com/article/ca-out-equal-idUSnBw125225a+100+BSW20151012,
20151014 7:30AM UTC,Johnson & Johnson Reports 2015 Third-Quarter Results:,http://www.reuters.com/article/jj-3q-earns-idUSnPn87wfjL+81+PRN20151013,
20151014 7:23AM UTC,Johnson & Johnson plans to buy back shares up to $10 billion,http://www.reuters.com/article/us-johnson-johnson-buyback-idUSKCN0S719V20151013,
20151014 6:59AM UTC,Johnson & Johnson to buy back shares up to $10 bln,http://www.reuters.com/article/johnsonjohnson-buyback-idUSL3N12D3YN20151013,
20151014 6:45AM UTC,Johnson & Johnson Announces $10 Billion Share Repurchase Program,http://www.reuters.com/article/nj-johnson-johnson-idUSnPn9GbpVQ+93+PRN20151013,
20151014 2:28PM UTC,Johnson & Johnson hit by strong dollar,http://www.reuters.com/news/video/videoStory?storyID=112610883,
20151020 8:11AM UTC,Johnson & Johnson's Stelara succeeds in Phase III Crohn's disease trial,http://www.reuters.com/article/us-johnson-johnson-crohn-s-idUSKCN0SD1DS20151019,
20151023 1:26PM UTC,Johnson & Johnson Announces Quarterly Dividend for Fourth Quarter 2015,http://www.reuters.com/article/johnsonjohnson-div-idUSnPn6MqbcS+91+PRN20151022,
20151028 5:03PM UTC,Johnson & Johnson to Participate in the 24th Annual Credit Suisse Health Care Conference,http://www.reuters.com/article/johnsonjohnsonwebcst-idUSnPn2QxpKl+92+PRN20151027,
20151029 1:54PM UTC,"Research and Markets: Global HIV Drugs Market 2015-2019 - Key Vendors are Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline, Johnson & Johnson & Merck",http://www.reuters.com/article/research-and-markets-idUSnBw286395a+100+BSW20151028,
20151104 8:34AM UTC,Johnson & Johnson HIV combination succeeds in mid-stage study,http://www.reuters.com/article/johnsonjohnson-study-idUSL3N12Y3WB20151103,
20151105 12:38PM UTC,Novira Therapeutics Announces Acquisition Agreement with Johnson & Johnson,http://www.reuters.com/article/novira-acquire-by-jj-idUSnPnbXpQtD+95+PRN20151104,
20151105 12:01PM UTC,"Johnson & Johnson Announces Agreement To Acquire Novira Therapeutics, Inc.",http://www.reuters.com/article/johnsonjohnsonacquir-idUSnPn4W4n5m+90+PRN20151104,
20151114 9:00AM UTC,Johnson & Johnson Consumer Inc.'s Care to Recycle Program and Scholastic Announce Winners of National Recycling Contest: PETE's Bathroom Bin Challenge,http://www.reuters.com/article/johnson-johnson-idUSnPn9NfjW4+92+PRN20151113,
20151117 6:12AM UTC,"Research and Markets: Global Extremities Market Report: 2015 Edition - Major Players are Johnson & Johnson, Stryker, Zimmer and Wright Medical",http://www.reuters.com/article/research-and-markets-idUSnBw165637a+100+BSW20151116,
20151118 4:30PM UTC,Johnson & Johnson Announces $1.75 Million Donation to Save the Children to Support Syrian Humanitarian Refugee Crisis,http://www.reuters.com/article/johnsonjohnson-donate-idUSnPn801VxX+85+PRN20151117,
20151128 12:49PM UTC,"Research and Markets: Global Spine Market Report: 2015 Edition Featuring Medtronic Inc., Johnson & Johnson, Stryker Corporation, and Nuvasive Inc",http://www.reuters.com/article/research-and-markets-idUSnBw275332a+100+BSW20151127,
20151202 10:00AM UTC,Johnson & Johnson Marks World AIDS Day with Major New Global Commitments to End HIV Infection in Adolescent Girls and Women,http://www.reuters.com/article/johnson-johnson-aids-idUSnPn3VJ095+98+PRN20151201,
20151205 4:30PM UTC,"Johnson & Johnson Announces Completion Of Novira Therapeutics, Inc. Acquisition",http://www.reuters.com/article/johnsonjohnsonnovira-idUSnPn2856BP+83+PRN20151204,
20151211 9:00AM UTC,"Johnson & Johnson Announces Formation Of Verb Surgical Inc., In Collaboration With Verily",http://www.reuters.com/article/johnsonjohnson-verb-idUSnPn7BYbhn+98+PRN20151210,
20151212 9:00AM UTC,"Alexander Law Group, LLP Wins $9.8 Million Judgment Against Johnson & Johnson Healthcare Systems and Ethicon Endo-Surgery",http://www.reuters.com/article/ca-alexander-law-group-idUSnBw115175a+100+BSW20151211,
20151216 10:06AM UTC,"CORRECTING and REPLACING Alexander Law Group, LLP Wins $70 Million Punitive Judgment Against Johnson & Johnson Subsidiary Ethicon Endo-Surgery",http://www.reuters.com/article/cqn-ca-alexander-law-gr-idUSnBw146468a+100+BSW20151215,
20151224 5:53PM UTC,"Kentucky reaches $39.5 million settlement with Purdue, Johnson & Johnson",http://www.reuters.com/article/us-kentucky-settlement-idUSKBN0U629120151223,
20151224 5:41PM UTC,"Kentucky reaches $39.5 mln settlement with Purdue, Johnson & Johnson",http://www.reuters.com/article/kentucky-settlement-idUSL3N14C48520151223,
20160112 10:07AM UTC,U.S. justices reject Johnson & Johnson unit's anti-psychotic drug appeal,http://www.reuters.com/article/usa-court-johnsonjohnson-idUSL2N14V14520160111,
20160112 10:05AM UTC,U.S. justices reject Johnson & Johnson unit's anti-psychotic drug appeal,http://www.reuters.com/article/us-usa-court-johnson-johnson-idUSKCN0UP1LM20160111,
20160112 10:05AM UTC,UPDATE 1-U.S. justices reject Johnson & Johnson unit's anti-psychotic drug appeal,http://www.reuters.com/article/usa-court-johnsonjohnson-idUSL2N14V11G20160111,
20160112 9:40AM UTC,U.S. top court rejects Johnson & Johnson unit's appeal of $124 mln penalty,http://www.reuters.com/article/usa-court-johnsonjohnson-idUSW1N13P01N20160111,
20160318 4:19PM UTC,Johnson & Johnson hit with $500 million verdict in hip implant trial,http://www.reuters.com/article/us-johnson-johnson-lawsuit-verdict-idUSKCN0WJ2I2,
20160318 1:09PM UTC,Johnson & Johnson hit with $500 mln verdict in trial over hip implants,http://www.reuters.com/article/johnsonjohnson-lawsuit-verdict-idUSL2N16P1CG,
20160319 9:53AM UTC,BRIEF-Johnson & Johnson says Stelara induced clinical response and remission in Phase 3 study,http://www.reuters.com/article/idUSFWN16Q0C1,
20160414 6:42AM UTC,Johnson & Johnson unit liable for poaching rival's employee - 8th Circuit,http://www.reuters.com/article/employment-noncompete-idUSL2N17G0D8,
20160420 7:13AM UTC,BRIEF-Johnson & Johnson reports Q1 EPS of $1.54,http://www.reuters.com/article/idUSASD08E0S,
20160427 4:50PM UTC,BRIEF-Johnson & Johnson Consumer to buy Neostrata Co,http://www.reuters.com/article/idUSASD08FGV,
20160429 10:32AM UTC,BRIEF-Johnson & Johnson announces dividend increase of 6.7 pct,http://www.reuters.com/article/idUSASD08FW6,
20160504 12:24PM UTC,Johnson & Johnson ordered to pay $55 mln in talc-powder trial,http://www.reuters.com/article/us-johnson-johnson-talc-verdict-idUSKCN0XT20L,
20160511 8:54AM UTC,UPDATE 1-Triple A Johnson & Johnson jumps on euro bond bandwagon,http://www.reuters.com/article/johnsonjohnson-bonds-idUSL5N1874PJ,
20160511 7:28AM UTC,Triple A Johnson & Johnson jumps on euro bond bandwagon,http://www.reuters.com/article/johnsonjohnson-bonds-idUSL5N1872RI,
20160511 6:40AM UTC,BRIEF-Johnson & Johnson says Janssen unit received civil investigative demand from U.S. Attorney's office for Southern district of New York,http://www.reuters.com/article/idUSFWN1870N7,
20160512 4:54AM UTC,Fitch Rates Johnson & Johnson's Euro Notes Offering 'AAA'; Outlook Stable,http://www.reuters.com/article/idUSFit958516,
20160518 8:52AM UTC,BRIEF-Johnson & Johnson says collaborating with HP Inc's unit,http://www.reuters.com/article/idUSFWN18E0AN,
20160525 4:42PM UTC,California sues Johnson & Johnson over marketing for pelvic mesh,http://www.reuters.com/article/johnsonjohnson-mesh-lawsuit-idUSL2N18L205,
20160525 4:41PM UTC,California sues Johnson & Johnson over marketing for pelvic mesh,http://www.reuters.com/article/us-johnson-johnson-mesh-lawsuit-idUSKCN0YF2LC,
20160525 4:39PM UTC,UPDATE 2-California sues Johnson & Johnson over marketing for pelvic mesh,http://www.reuters.com/article/johnsonjohnson-mesh-lawsuit-idUSL2N18L1PY,
20160525 3:07PM UTC,California AG sues Johnson & Johnson over marketing for pelvic mesh,http://www.reuters.com/article/johnsonjohnson-mesh-lawsuit-idUSL2N18L1OK,
20160720 12:52PM UTC,"Johnson & Johnson raises 2016 forecast, shares touch record high",http://www.reuters.com/article/us-johnson-johnson-results-idUSKCN0ZZ15V,
20160720 12:52PM UTC,"UPDATE 4-Johnson & Johnson raises 2016 forecast, shares touch record high",http://www.reuters.com/article/johnsonjohnson-results-idUSL4N1A53AQ,
20160720 7:03AM UTC,BRIEF-Johnson & Johnson posts Q2 earnings of $1.43/share,http://www.reuters.com/article/idUSASC08X97,
20160601 7:12AM UTC,BRIEF-European Commission approves Johnson & Johnson's TREVICTA,http://www.reuters.com/article/idUSFWN18S09B,
20160603 6:57AM UTC,BRIEF-Johnson & Johnson to acquire Vogue International for about $3.3 bln,http://www.reuters.com/article/idUSASC08SCK,
20160607 8:51AM UTC,BRIEF-Amyris announces collaboration with Johnson & Johnson Innovation,http://www.reuters.com/article/idUSFWN18Y0EA,
20160701 11:09AM UTC,BRIEF-Fitch affirms Johnson & Johnson's IDR at 'AAA'; outlook stable,http://www.reuters.com/article/idUSFWN19M0ON,
20160701 10:03AM UTC,Fitch Affirms Johnson & Johnson's IDR at 'AAA'; Outlook Stable,http://www.reuters.com/article/idUSFit965809,
20160712 2:24PM UTC,BRIEF-Johnson & Johnson to buy 20 pct stake in CI:Z Holdings Co - Nikkei,http://www.reuters.com/article/idUSFWN19X0OI,
20160719 4:34PM UTC,BRIEF-Johnson & Johnson announces completion of Vogue International deal,http://www.reuters.com/article/idUSFWN1A40IZ,
20160719 2:34PM UTC,BRIEF-Johnson & Johnson sets quarterly cash dividend of $0.80 per share,http://www.reuters.com/article/idUSFWN1A40IF,
20160818 2:00PM UTC,BRIEF-Johnson & Johnson announces ruling related to Remicade,http://www.reuters.com/article/idUSFWN1AY0SL,
20160820 10:31AM UTC,BRIEF-Johnson & Johnson reports 15 pct passive stake in Protagonist Therapeutics - SEC filing,http://www.reuters.com/article/idUSFWN1B00P8,
20160917 3:05PM UTC,BRIEF-Abbott to sell Abbott Medical Optics to Johnson & Johnson for $4.325 bln,http://www.reuters.com/article/idUSFWN1BS0AN,
20160917 3:05PM UTC,BRIEF-Johnson & Johnson to buy Abbott Medical Optics for $4.325 bln,http://www.reuters.com/article/idUSASC096M8,
20160929 8:21AM UTC,BRIEF-Tracon Pharmaceuticals announces a strategic licensing collaboration for two Janssen Oncology assets and a $5 mln equity investment from Johnson & Johnson Innovation - JJDC Inc,http://www.reuters.com/article/idUSASC099I7,
20161005 8:30AM UTC,Johnson & Johnson letter on cyber bug in insulin pump,http://www.reuters.com/article/us-johnson-johnson-cyber-insulin-pumps-t-idUSKCN12414G,
20161019 7:10AM UTC,BRIEF-Johnson & Johnson reports Q3 EPS $1.53,http://www.reuters.com/article/idUSASC09BI3,
20161101 3:25PM UTC,BRIEF-Johnson & Johnson reports 6.4 pct passive stake in Tracon Pharmaceuticals,http://www.reuters.com/article/idUSFWN1D10ZX,
20161115 5:38PM UTC,"BRIEF-Paulson & Co cuts share stake in Alexion Pharmaceuticals, Johnson & Johnson",http://www.reuters.com/article/idUSFWN1DF1JG,
20161126 7:04PM UTC,"Biotech group Actelion, Johnson & Johnson confirm deal talks",http://www.reuters.com/article/actelion-ma-johnsonjohnson-idUSL1N1DQ0V2,
20161126 7:03PM UTC,Johnson & Johnson approaches Actelion about takeover deal,http://www.reuters.com/article/us-actelion-m-a-johnson-johnson-shares-idUSKBN13K1F0,
20161126 7:02PM UTC,UPDATE 4-Johnson & Johnson approaches Actelion about takeover deal,http://www.reuters.com/article/actelion-ma-johnsonjohnson-idUSL8N1DQ3JP,
20161126 11:08AM UTC,Actelion confirms Johnson & Johnson approach,http://www.reuters.com/article/us-actelion-m-a-johnson-johnson-approach-idUSKBN13K1U1,
20161126 11:06AM UTC,Actelion confirms Johnson & Johnson approach,http://www.reuters.com/article/actelion-ma-johnsonjohnson-approach-idUSFWN1DQ0FZ,
20161202 7:37PM UTC,Johnson & Johnson hit with over $1 billion verdict on hip implants,http://www.reuters.com/article/us-johnson-johnson-verdict-hipimplants-idUSKBN13Q5XF,
20161202 7:07PM UTC,Johnson & Johnson hit with over $1 bln verdict on hip implants,http://www.reuters.com/article/johnsonjohnson-verdict-hipimplants-idUSL1N1DW2LY,
20161202 7:05PM UTC,UPDATE 2-Johnson & Johnson hit with over $1 bln verdict on hip implants,http://www.reuters.com/article/johnsonjohnson-verdict-hipimplants-idUSL1N1DW2K0,
20161202 5:46PM UTC,Johnson & Johnson hit with over $1 bln verdict on hip implants,http://www.reuters.com/article/johnsonjohnson-verdict-hipimplants-idUSL1N1DW2JH,
20161212 4:54PM UTC,Johnson & Johnson shares could rally about 20 percent: Barron's,http://www.reuters.com/article/us-johnson-johnson-barrons-idUSKBN14013D,
20161214 6:42PM UTC,BRIEF-Johnson & Johnson says it has ended discussions with Actelion,http://www.reuters.com/article/idUSFWN1E80SB,
20170104 6:41AM UTC,BRIEF-Johnson & Johnson announces quarterly dividend for Q1 2017,http://www.reuters.com/article/idUSFWN1ET0A7,
20170112 7:21PM UTC,BRIEF-Orthocell announces collaboration with Johnson & Johnson,http://www.reuters.com/article/idUSFWN1F10UT,
20170119 5:59PM UTC,"BRIEF-Johnson & Johnson reports 7.4 pct stake in Merus NV as of Dec 31, 2016",http://www.reuters.com/article/idUSFWN1F80QO,
20170128 4:14PM UTC,BRIEF-Fitch affirms Johnson & Johnson's IDR at 'AAA'; outlook stable,http://www.reuters.com/article/idUSFWN1FH0W3,
20170128 3:42PM UTC,Fitch Affirms Johnson & Johnson's IDR at 'AAA'; Outlook Stable,http://www.reuters.com/article/idUSFit988039,
20170208 8:00AM UTC,"BRIEF-State Street Corp reports a 5.65 pct passive stake in Johnson & Johnson, as of Dec. 31",http://www.reuters.com/article/idUSFWN1FS0ES,
20170216 7:24AM UTC,BRIEF-Integra Lifesciences plans to acquire Codman neurosurgery business from Johnson & Johnson for $1.045 bln,http://www.reuters.com/article/idUSASB0B0DC,
20170228 5:20PM UTC,BRIEF-Johnson & Johnson says received a subpoena in Feb. from the U.S. attorney's office for the District of Massachusetts,http://www.reuters.com/article/brief-johnson-johnson-says-received-a-su-idUSFWN1GC14G,
20170301 11:38AM UTC,Fitch Rates Johnson & Johnson's Notes Offering 'AAA'; Outlook Stable,http://www.reuters.com/article/fitch-rates-johnson-johnsons-notes-offer-idUSFit990515,
20170304 5:00PM UTC,Johnson & Johnson wins trial in talc product liability lawsuits,http://www.reuters.com/article/us-johnson-johnson-cancer-lawsuit-idUSKBN16A2J4,
20170304 7:43AM UTC,BRIEF-Johnson & Johnson's Janssen says new results from second phase 3 study show significant efficacy of guselkumab,http://www.reuters.com/article/brief-johnson-johnsons-janssen-says-new-idUSFWN1GG0FJ,
20170324 8:24AM UTC,BRIEF-Johnson & Johnson says to pause all YouTube digital advertising globally,http://www.reuters.com/article/brief-johnson-johnson-says-to-pause-all-idUSFWN1H00FM,
20170401 1:08AM UTC,BRIEF-Johnson & Johnson says Janssen Holding to acquire all publicly held shares of Actelion for $280 per share,http://www.reuters.com/article/brief-johnson-johnson-says-janssen-holdi-idUSFWN1H800N,
20170413 7:14AM UTC,BRIEF-Phagelux announces collaboration with Johnson & Johnson Innovation for new antibacterial solution,http://www.reuters.com/article/brief-phagelux-announces-collaboration-w/brief-phagelux-announces-collaboration-with-johnson-johnson-innovation-for-new-antibacterial-solution-idUSFWN1HK0BS,
20170419 9:36AM UTC,BRIEF-Johnson & Johnson sees Actelion adding 35-50 cents to 2018 EPS,http://www.reuters.com/article/brief-johnson-johnson-sees-actelion-addi/brief-johnson-johnson-sees-actelion-adding-35-50-cents-to-2018-eps-idUSL1N1HQ0MA,
20170419 6:50AM UTC,BRIEF-Johnson & Johnson Q1 earnings per share $1.61,http://www.reuters.com/article/brief-johnson-johnson-q1-earnings-per-sh/brief-johnson-johnson-q1-earnings-per-share-1-61-idUSASA09IX3,
20170610 2:31PM UTC,"BRIEF-Johnson & Johnson says expects settlement of Actelion tender offer on June 16, 2017",http://www.reuters.com/article/brief-johnson-johnson-says-expects-settl/brief-johnson-johnson-says-expects-settlement-of-actelion-tender-offer-on-june-16-2017-idUSFWN1J60G6,
20170610 12:28PM UTC,Johnson & Johnson expects to complete Actelion purchase on June 16,http://www.reuters.com/article/us-actelion-m-a-johnson-johnson-eu/johnson-johnson-expects-to-complete-actelion-purchase-on-june-16-idUSKBN1901MU,
20170610 12:24PM UTC,UPDATE 1-Johnson & Johnson expects to complete Actelion purchase on June 16,http://www.reuters.com/article/swiss-actelion/update-1-johnson-johnson-expects-to-complete-actelion-purchase-on-june-16-idUSL8N1J650J,
20170610 11:59AM UTC,Johnson & Johnson expects to complete of Actelion offer on June 16,http://www.reuters.com/article/us-actelion-m-a-johnson-johnson-deal/johnson-johnson-expects-to-complete-of-actelion-offer-on-june-16-idUSKBN1902D5,
20170610 11:52AM UTC,Johnson & Johnson expects to complete of Actelion offer on June 16,http://www.reuters.com/article/idUSZ8N1E901K,
20170615 9:44AM UTC,Johnson & Johnson's flu drug succeeds in mid-stage trial,http://www.reuters.com/article/us-johnson-johnson-trial/johnson-johnsons-flu-drug-succeeds-in-mid-stage-trial-idUSKBN1951GC,
20170615 9:37AM UTC,UPDATE 2-Johnson & Johnson's flu drug succeeds in mid-stage trial,http://www.reuters.com/article/johnsonjohnson-trial/update-2-johnson-johnsons-flu-drug-succeeds-in-mid-stage-trial-idUSL3N1JB3ZO,
20170615 8:30AM UTC,BRIEF-Johnson & Johnson says are working with medical University of South Carolina,http://www.reuters.com/article/brief-johnson-johnson-says-are-working-w/brief-johnson-johnson-says-are-working-with-medical-university-of-south-carolina-idUSFWN1JB0HN,
20170615 7:12AM UTC,Johnson & Johnson's flu drug succeeds in mid-stage trial,http://www.reuters.com/article/johnsonjohnson-trial/johnson-johnsons-flu-drug-succeeds-in-mid-stage-trial-idUSL3N1JB3XU,
20170617 1:04AM UTC,BRIEF-Johnson & Johnson announces completion of acquisition of Actelion,http://www.reuters.com/article/brief-johnson-johnson-announces-completi/brief-johnson-johnson-announces-completion-of-acquisition-of-actelion-idUSASA09U3S,
20170705 10:27AM UTC,Australian class action suit filed against Johnson & Johnson over pelvic mesh,http://www.reuters.com/article/us-johnson-johnson-australia/australian-class-action-suit-filed-against-johnson-johnson-over-pelvic-mesh-idUSKBN19P0ZX,
20170705 5:09AM UTC,Australian class action suit filed against Johnson & Johnson over pelvic mesh,http://www.reuters.com/article/johnsonjohnson-australia/australian-class-action-suit-filed-against-johnson-johnson-over-pelvic-mesh-idUSL3N1JV2PC,
20170705 7:44AM UTC,Australian legal action against Johnson & Johnson,http://www.reuters.com/news/video/videoStory?storyID=130531840,
20170719 6:58AM UTC,BRIEF-Johnson & Johnson Q2 earnings per share $1.40,http://www.reuters.com/article/brief-johnson-johnson-q2-earnings-per-sh/brief-johnson-johnson-q2-earnings-per-share-1-40-idUSASB0B9DM,
20170725 11:34AM UTC,"US STOCKS-S&P;, Dow lower as Johnson & Johnson drags",http://www.reuters.com/article/usa-stocks/us-stocks-sp-dow-lower-as-johnson-johnson-drags-idUSL3N1KF4Q2,
20170725 4:04AM UTC,BRIEF-Johnson & Johnson announces encouraging first-in-human clinical data for investigational HIV preventive vaccine,http://www.reuters.com/article/brief-johnson-johnson-announces-encourag/brief-johnson-johnson-announces-encouraging-first-in-human-clinical-data-for-investigational-hiv-preventive-vaccine-idUSFWN1KF05O,
20170728 5:30AM UTC,BRIEF-Proteros enters into new research collaboration with Johnson & Johnson innovation on sub-class of epigenetic targets,http://www.reuters.com/article/brief-proteros-enters-into-new-research/brief-proteros-enters-into-new-research-collaboration-with-johnson-johnson-innovation-on-sub-class-of-epigenetic-targets-idUSFWN1KI0F8,
20170803 6:31PM UTC,BRIEF- Johnson & Johnson says FDA advisory committee did not recommend approval of sirukumab,http://www.reuters.com/article/brief-johnson-johnson-says-fda-advisory/brief-johnson-johnson-says-fda-advisory-committee-did-not-recommend-approval-of-sirukumab-idUSASB0BCTJ,
20170810 2:26PM UTC,BRIEF-Bavarian Nordic announces price for shares to be issued to Johnson & Johnson Innovation,http://www.reuters.com/article/brief-bavarian-nordic-announces-price-fo/brief-bavarian-nordic-announces-price-for-shares-to-be-issued-to-johnson-johnson-innovation-idUSFWN1KV15P,
20170921 9:43AM UTC,Pfizer sues Johnson & Johnson over Remicade biosimilar,http://www.reuters.com/article/pfizer-trial-johnsonjohnson/pfizer-sues-johnson-johnson-over-remicade-biosimilar-idUSL4N1M1475,
20170921 9:39AM UTC,BRIEF-â€Pfizer files lawsuit against Johnson & Johnsonâ€‹,http://www.reuters.com/article/brief-pfizer-files-lawsuit-against-johns/brief-pfizer-files-lawsuit-against-johnson-johnson-idUSFWN1M10M9,
20171006 10:54AM UTC,Johnson & Johnson unit exits insulin pump business amid rising competition,http://www.reuters.com/article/us-johnson-johnson-insulin-pump/johnson-johnson-unit-exits-insulin-pump-business-amid-rising-competition-idUSKBN1CA1EL,
20171014 4:24PM UTC,BRIEF-Johnson & Johnson says FDA approves Stelara for adolescents with moderate to severe plaque psoriasis,http://www.reuters.com/article/brief-johnson-johnson-says-fda-approves/brief-johnson-johnson-says-fda-approves-stelara-for-adolescents-with-moderate-to-severe-plaque-psoriasis-idUSASB0BN24,
20171018 3:53PM UTC,Johnson & Johnson wins reversal of $72 million verdict over talc cancer risks,http://www.reuters.com/article/us-johnson-johnson-cancer-lawsuit/johnson-johnson-wins-reversal-of-72-million-verdict-over-talc-cancer-risks-idUSKBN1CM2IF,
20171018 3:00PM UTC,New cancer drugs help Johnson & Johnson top profit estimates,http://www.reuters.com/article/us-johnson-johnson-results/new-cancer-drugs-help-johnson-johnson-top-profit-estimates-idUSKBN1CM1CN,
20171018 6:50AM UTC,BRIEF-Johnson & Johnson Q3 earnings per share $1.37,http://www.reuters.com/article/brief-johnson-johnson-q3-earnings-per-sh/brief-johnson-johnson-q3-earnings-per-share-1-37-idUSASB0BNA1,
20171020 7:10AM UTC,BRIEF-Arcturus Therapeutics to collaborate with Johnson & Johnson,http://www.reuters.com/article/brief-arcturus-therapeutics-to-collabora/brief-arcturus-therapeutics-to-collaborate-with-johnson-johnson-idUSFWN1MU0KV,
20171020 6:15AM UTC,BRIEF-â€Johnson & Johnson Medical GmbH to acquire Surgical Process Instituteâ€‹,http://www.reuters.com/article/brief-johnson-johnson-medical-gmbh-to-ac/brief-johnson-johnson-medical-gmbh-to-acquire-surgical-process-institute-idUSFWN1MU0K1,
20171022 12:27PM UTC,California judge tosses $417 million talc cancer verdict against Johnson & Johnson,http://www.reuters.com/article/us-johnson-johnson-cancer-lawsuit/california-judge-tosses-417-million-talc-cancer-verdict-against-johnson-johnson-idUSKBN1CQ003,
20171031 8:29AM UTC,BRIEF-Johnson & Johnson says FDA approved 10 mg dose of Xarelto for reducing continued risk for recurrent venous thromboembolismâ€‹,http://www.reuters.com/article/brief-johnson-johnson-says-fda-approved/brief-johnson-johnson-says-fda-approved-10-mg-dose-of-xarelto-for-reducing-continued-risk-for-recurrent-venous-thromboembolism-idUSASB0BPK7,
